Workshop: Cultured Meat Cost Trajectories (Late April / Early May 2026)
This page provides background for The Unjournal’s upcoming expert workshop on CM production costs. We’re bringing together TEA researchers, evaluators, and stakeholders to assess cost trajectories and identify key uncertainties. Join us
We Want Your Feedback
For substantive debate on biology, costs, or welfare — please post on 💬 GitHub Discussions. That’s where threaded conversation can get involved, with replies others can reply to and build on. Direct links:
🧠 Substantive hub — for biology, economics, engineering, and welfare debate (the main event)
🎯 PQ framing hub — for how we define the questions (jurisdiction forks, resolution criteria)
💬 Workshop hub — for session prep, agenda, and logistics
For quick inline notes on specific text, use Hypothesis (click the < tab on the right edge). For anything beyond a brief highlight, prefer GitHub Discussions so the conversation stays organized.
Cultured chicken (also called “cell-based” or “cultivated” chicken) is produced by growing avian muscle cells in bioreactors — essentially brewing meat instead of raising and slaughtering animals. Production costs have dropped dramatically — per GFI, the first cultured burger in 2013 “took months to produce and was reported to cost $330,000.” Today, optimistic projections suggest ~$63/kg (Garrison et al. 2022), with some companies claiming costs below $10/kg for pure cell mass (per a 2025 Lever VC industry report — note: authored by CM investors). These are costs for pure cultured cells, not finished consumer products, which may blend CM with plant-based or fungal ingredients at lower overall cost. This page explains the production process in detail and how each step affects costs. To explore these costs interactively, see our Monte Carlo cost model.
Cost Basis Matters: Read Carefully
Cost figures in the cultivated meat literature refer to different things depending on the study. Throughout this page, we label costs by their output basis where known:
Pure cell mass (wet weight): Cost to produce unprocessed cells in a bioreactor — this is what our dashboard model estimates
Cultivated ingredient: Cell mass after downstream processing (washing, concentration)
Hybrid product: A blend of cultivated cells with plant-based or other ingredients (e.g., 50/50 cultivated/plant-based)
Retail-equivalent product: Final consumer product including packaging, distribution, margins
A $14/kg figure for pure cell mass and a $14/kg figure for a 50/50 hybrid imply very different costs for the cultivated component. We try to flag the basis for every number cited below. See our TEA comparison page for a systematic breakdown.
The diagram below shows the high-level production flow. Each term is explained in detail in the sections that follow: Cell Bank → Seed Train → Production → Harvest → Processing → Product.
Why Chicken?
Several factors make chicken an attractive first target for cultured meat:
Factor
Advantage
Source
Cell biology
Chicken satellite cells can be cultured effectively and show robust viability
Estimated cost share: <1% of total production cost at scale
What Happens
A cell bank is a frozen inventory of starter cells that can be thawed and expanded for production. These cells are taken from a living animal (via biopsy) or from cell lines that have been immortalized for continuous growth. Cell banking follows standard biopharmaceutical protocols for master and working cell banks (Baust et al. 2016, GFI Technical Overview).
The diagram below shows the four steps of cell banking: (1) take a small biopsy from a living animal; (2) isolate cells — a tissue sample contains many cell types tangled together, so we use enzymatic digestion to separate individual cells from the tissue matrix; (3) expand the isolated cells by growing them in culture; (4) freeze them via cryopreservation (-196°C) for long-term storage.
Cell Types Used
Cell Type
Description
Pros
Cons
Source
Satellite cells (myoblasts)
Muscle stem cells that differentiate into muscle fibers
Cell banking is a one-time setup cost that’s amortized over many production runs.
How Cell Banking Costs Work (click to expand)
Think of it like this: - Initial cost: $50K-$500K to establish and characterize a cell bank - Cells produced: Billions of cells per vial, hundreds of vials per bank - Production supported: Each bank can support thousands of production batches
If a bank costs $200K and supports 10,000 batches of 1,000 kg each, the per-kg cost is: $200K ÷ 10M kg = $0.02/kg
This is negligible compared to media costs ($5-50/kg) and CAPEX ($2-10/kg). Cell banking typically represents <1% of total production cost at scale.
The cells aren’t “used up” in the traditional sense — each frozen vial is thawed and expanded by ~10 billion-fold before production. The bank only needs replacement when vials run out or cells lose performance.
A well-characterized cell bank can support years of production (GFI 2021).
Why the Hayflick Limit Matters (click to expand)
The Hayflick limit (doubling limit) of cells matters for cell banking logistics and cost, though the per-kg impact at scale is small (<1% of total):
Primary satellite cells can only double ~50-80 times before senescing (Hayflick 1965, Nature 2025)
This means you need frequent cell bank renewals (new biopsies, characterization, validation)
Immortalized lines eliminate this constraint — one cell bank can theoretically last forever
Trade-off: Immortalized cells may require GMO labeling and face regulatory scrutiny
Cost implication: If a cell line can produce 10× more batches before replacement, your per-batch cell banking cost drops by 10×.
Step 2: Seed Train (Scale-Up)
Estimated cost share: ~5-10% of total production cost (mostly labor)
What Happens
Cells are progressively expanded from small flasks to larger and larger bioreactors, typically increasing volume by ~10× at each step:
The diagram shows the typical progression: vial → T-flask (flat bottle for early culture) → spinner flask (small stirred vessel) → progressively larger bioreactors. Cell counts grow from millions (10⁶) to hundreds of billions (10¹¹+). Timeline shows typical days in culture.
Cost Impact
The seed train phase typically represents 5-15% of total production cost at scale. Per Humbird 2021: at 100 kTA scale, labor costs are “$1/kg wet cell mass” and consumables another “$1/kg”:
Uses expensive, small-scale equipment (research-grade, often single-use)
Requires manual handling and skilled labor ($50-150/hour fully loaded)
Consumes high-quality media (often pharma-grade at $5-20/L, though many companies now use food-grade at $0.50-2/L)
Are Companies Still Using Pharma-Grade? (click to expand)
Increasingly, no. While early R&D relied heavily on pharma-grade media and equipment, most companies scaling up have transitioned to food-grade alternatives. Per a 2025 industry report:
Media: “costs $1 per liter or less and several are under $0.50 per liter” — “10-30× cheaper than [Humbird 2021] thought possible”
Equipment: Vow built a 20,000L bioreactor “well under $1 million” (80% below off-the-shelf costs)
Cell density: Companies achieving “60-90 g/L” vs Humbird’s 60 g/L maximum projection
Per the same report, production COGS for cell mass are claimed to be “$10-15/kg, with some leading-edge companies claiming costs below $10/kg” — up to 50% lower than the 2021 projections. Note: these claims come from a Lever VC report authored by CM investors and have not been independently verified.
Why Cell Density is So Important (click to expand)
Cell density is one of the most important parameters for cost:
Density
Media needed for 1 kg meat
Relative media cost
Est. media cost/kg (at $1/L)
30 g/L
33 liters
100% (baseline)
~$33/kg
100 g/L
10 liters
30%
~$10/kg
200 g/L
5 liters
15%
~$5/kg
Higher density means:
Less media per kg of meat (biggest savings)
Fewer reactor transfers in seed train
Smaller bioreactors needed for same output
Lower labor per kg
Current densities: 30-50 g/L (batch), 60-90 g/L (commercial per 2025 industry report), up to 360 g/L in perfusion (PMC 2025)
Step 3: Production Bioreactors
Estimated cost share: 15-35% of total production cost (bioreactor CAPEX + buildings)
The Core Technology
Production-scale bioreactors are the heart of cultured meat manufacturing. They must:
Maintain sterility — Any contamination means losing the entire batch ($100K-$1M+ loss per batch in biopharma; see Kelley 2009, Cytiva)
Supply oxygen — Cells need O₂ but are shear-sensitive
Remove CO₂ — Metabolic waste that acidifies media
Control temperature — Typically 37°C ± 0.5°C for mammalian cells (avian cells similar)
The diagram below shows a standard stirred-tank bioreactor. Key components: the impeller (rotating blades that mix the culture), the sparger (bubbles oxygen into the media), and ports for adding media and harvesting cells.
Bioreactor Types
Different bioreactor designs make different trade-offs between cost, scale, and cell type compatibility. Most cultured meat R&D currently uses stirred-tank reactors (the pharmaceutical industry standard), but companies are actively developing custom food-grade designs to reduce costs.
Which Type Will Win? (click to expand)
The industry hasn’t converged on a single design yet. Key factors:
Stirred-tank: Proven, well-understood, but expensive. Used by most companies today.
Air-lift: Gentler on cells, potentially cheaper, but less established.
Packed-bed: Required for structured products (steaks), but harder to scale.
Custom food-grade: Already in use by some companies (e.g., Vow) — the key question is whether sterility can be maintained at scale.
Companies like UPSIDE Foods and Believer Meats have built large-scale facilities using modified pharma equipment, while others (Vow, etc.) are now operating custom food-grade bioreactors at substantially lower cost.
Why Bioreactor Costs Are Pivotal (click to expand)
Bioreactor CAPEX accounts for roughly 15-35% of total production cost at scale, making it a pivotal cost driver. Pharma-grade stainless steel bioreactors cost $50-500/L installed (Humbird 2021, PMC 2024).
The opportunity — already being realized: Several companies are now using simplified food-grade designs (similar to beer brewing at $5-15/L). Vow (Australia) has built custom food-grade bioreactors at ~80% below pharma costs, and other companies are following suit. If this approach scales successfully, equipment costs could drop by 10x industry-wide.
Equipment Type
Cost per Liter
Example Industry
Pharma-grade bioreactor
$50-500/L
Vaccine production
Food-grade fermentation
$10-50/L
Specialty ingredients
Beer brewing tanks
$5-15/L
Craft breweries
Key question: Can cultured meat production maintain sterility and consistency with simpler equipment? This depends on whether the process can tolerate: - Less precise temperature control - Simpler cleaning validation - Lower-grade materials (304 vs 316L stainless)
Contamination is a real risk: Per a 2024 industry survey, cultivated meat companies reported an average microbiological batch failure rate of 11.2% (climbing to 19.5% at commercial scale). Primary contamination vectors included improper equipment sterilization and exposure during cell harvest. By comparison, the biopharmaceutical industry experiences contamination failures in only ~3.2% of batches at commercial facilities. This helps explain why many cultured meat companies have historically relied on pharma-grade equipment, though the trend is shifting: companies like Vow and others are now building custom food-grade bioreactors at substantially lower cost (per a 2025 Lever VC report, Vow built a 20,000L bioreactor “well under $1 million,” 80% below off-the-shelf costs).
Batch vs. Perfusion: Two Operating Modes
TL;DR: Batch mode (fill, grow, harvest) is simpler and cheaper to operate but limited to ~30-50 g/L cell density. Perfusion mode (continuous fresh media flow) achieves 100-200+ g/L density but costs more in equipment and media volume. The choice maps directly to the media-use multiplier parameter in our cost model: batch ≈ 1, perfusion ≈ 2–3, media recycling or fed-batch ≈ 0.5–1. Values below 1 are discussed in the next section.
Details: How batch vs. perfusion works (click to expand)
The choice of operating mode is not about different bioreactor types — it is about how nutrients are delivered and waste removed within the same basic stirred-tank reactor described above. This choice significantly affects achievable cell density and economics.
Batch mode: Fill → Grow → Harvest all. Simple but limited density.
Perfusion mode: Continuous flow of fresh media, removing waste while retaining cells. Complex but much higher density.
The diagram compares these two operating modes side-by-side. Batch mode (left) harvests everything at once; perfusion (right) continuously adds fresh media and removes spent media while retaining cells.
The media-use multiplier parameter in our interactive model captures this regime, and a few others:
Multiplier ≈ 1: Batch mode (one reactor fill per kg of cells)
Multiplier ≈ 2–3: Standard perfusion
Multiplier < 1: Media recycling, fed-batch with concentrated feeds, or harvest-side cell concentration — see the three mechanisms below
At 50 g/L density the nominal reactor-fill volume is 20 L/kg — “one reactor filling, containing 1 kg of cells at 50 g/L.” At 100 g/L it’s 10 L/kg. A multiplier of 1 means you consumed exactly that much fresh media. Values above 1 are straightforward: perfusion systems continuously flow fresh media through, and over a batch you cumulatively use several reactor volumes. Values below 1 feel surprising at first but correspond to three very real mechanisms.
1. Media recycling. Spent media can be filtered (e.g., by tangential flow filtration), depleted nutrients replenished, and fed back into the reactor. If you recover and reuse 50% of your spent media, your net fresh media consumption per kg of cells is half the nominal reactor volume — multiplier ≈ 0.5. Aggressive recycling is cited in GFI’s 2025 review as likely necessary for reaching commercially viable cultivated-meat costs.
2. Fed-batch with concentrated feeds. Instead of flowing large volumes of dilute fresh media through the reactor, you start at a fraction of the working volume with full-strength media and then add small volumes of concentrated glucose / amino-acid / buffer solution as cells consume substrate. The total liquid media consumed over the run can be less than one nominal reactor volume, because most of the added mass is dissolved solute rather than water. Industrial microbial fermentation has been run this way for decades; for cultivated meat it maps to multipliers of ≈ 0.6–0.9.
3. Harvest-side cell concentration. If cells are concentrated after they finish growing — via settling, centrifugation, or filtration — you can extract 1 kg of cells from less media than 1000 / (growth density) suggests. For example, running the reactor at 50 g/L growth density but harvesting a 200 g/L slurry means you’re pulling 1 kg of cells out of 5 L of media, not 20 L. The baseline formula doesn’t have a separate knob for harvest concentration, so the multiplier absorbs that correction — values around 0.25–0.5 can appear this way without any recycling or fed-batch logic.
Why the model’s default range includes values below 1
The GFI 2023 recombinant-protein report assumes 8–13 L media per kg of meat as its cost-competitive scenario. Our dashboard lets you push cell density up to ~90 g/L. At 90 g/L:
So to hit the GFI upper bound of 13 L/kg at 90 g/L, you need multiplier ≈ 1.17. To hit the lower bound of 8 L/kg at 90 g/L, you need multiplier ≈ 0.72. At a more typical 60 g/L density, the nominal is 16.7 L/kg, and GFI’s 8–13 L/kg implies multipliers of 0.48–0.78. None of those scenarios are reachable with a floor of 1.0 — no matter how high cell density goes. That’s why the model’s default sampling range is now 0.5–3.0 rather than the earlier 1–10.
Values above 5× remain plausible for heavily media-intensive processes but are no longer part of the default sampled range; treat them as stress tests for pessimistic scenarios.
What this does NOT mean
It does not mean less than one reactor-filling’s worth of liquid physically entered the vessel. It means less than one nominal reactor-filling-equivalent of fresh media was consumed, once recycling, concentration, and fed-batch feed schedules are all counted as they affect the $/kg cost calculation.
It does not mean perfusion systems are being misrepresented — a perfusion reactor with aggressive media recycling can legitimately operate at an overall multiplier below 1 even though its instantaneous media-change rate is above 1.
The model uses a single bundled parameter rather than separate knobs for turnover, recycle fraction, and harvest concentration. That’s a simplification; a future revision may split them.
360 g/L: Per PMC 2025: “harvested…cultured fat at 360 g/L” with “1.5 years of continuous culture and over 600 cell divisions”
1.3 x 1011 cells/L: Believer Meats 2024 study using $0.63/L media, achieving $6.20/lb (~$13.67/kg) cultivated chicken
Batch vs Perfusion Trade-offs (click to expand)
Factor
Batch Mode
Perfusion Mode
Cell density
30-50 g/L max
100-200+ g/L
Media usage
Lower total volume (multiplier ≈ 1, or ≈ 0.5–0.9 with fed-batch/recycling)
Higher (multiplier ≈ 2–3 standard, up to 5–10 stress-test)
Equipment
Simpler
More complex (pumps, filters)
Contamination risk
Lower (closed system)
Higher (more connections)
Cycle time
5-10 days
Continuous
The batch/perfusion distinction is a simplification. In practice, cell density, media-use multiplier, and recycle fraction are interdependent — higher perfusion density may require additional retention devices (e.g., ATF filters), and media recycling can partially decouple the multiplier from fresh media cost. Our dashboard model treats density and the media-use multiplier as separate parameters for simplicity, with the multiplier bundling recycling and harvest concentration (see Media-use mechanisms); see Technical Reference for how these interact in the cost equations.
Per Humbird 2021: fed-batch achieves $37/kg wet cell mass (or $22/kg with hydrolysates), while perfusion costs $51/kg wet cell mass due to higher CAPEX ($23/kg capital charge) and consumables (ATF membranes at $16k each, 20 per bioreactor per year). Perfusion’s higher density doesn’t always offset equipment costs at current scales. Note: Humbird models generic mammalian cells, not chicken specifically.
Media Composition: 40-70% of Total Cost
Estimated cost share: 40-70% of total production cost — the single largest cost component
Why This Isn’t a “Step” (click to expand)
Media composition isn’t sequential — it’s used throughout the production process (in seed train and production bioreactors). We cover it separately because understanding media costs is essential for understanding overall economics.
Cell culture media contains everything cells need to grow. Below are components ordered by approximate share of total media cost at production scale:
Component
% of Media Cost
Function
Key Cost Driver
Amino acids
30-50%
Building blocks for proteins
Hydrolysates vs. pharma-grade
Growth factors
5-60%*
Signaling proteins (FGF, IGF, TGF-β)
Technology breakthrough?
Glucose
5-15%
Energy source
Commodity (~$0.50/kg)
Vitamins
3-8%
Metabolic cofactors
B-complex, etc.
Lipids
2-5%
Cell membrane building
~$0.10-0.50/L
Minerals/salts
1-3%
Osmotic balance, enzyme function
Cheap (<$0.10/L)
Components above are listed by approximate share of media cost (largest first). The bottom three (vitamins, lipids, minerals) together account for only ~5-15% of media cost and are already available at commodity prices — they are not significant cost drivers.
*Growth factor share varies enormously: at research scale GFs can be 55-95% of media cost (Specht 2020). At production scale, projections range from 5-60% depending on technology assumptions — potentially <5% if breakthrough technologies succeed. Based on multiple TEA analyses, this appears to be one of the larger uncertainties in cultured meat economics.
Media = 40-70% of Total Production Cost (click for breakdown)
At production scale, media (including growth factors) typically represents 40-70% of total production cost. Per PMC 2024: “The culture medium represents the most significant cost in CM production, accounting for 55%–95% of total expenses” at current scales. At optimized scales, this drops to 40-70% (Humbird 2021, Risner et al. 2021, GFI 2024).
Cost Component
Share of Total
Humbird 2021 $/kg
Media (all components)
40-70%
$22/kg (or $6 with hydrolysates)
Capital costs (bioreactors)
15-35%
$12/kg
Fixed OPEX (labor, overhead)
10-25%
$3/kg
Downstream processing
2-15%
—
This is why media cost reduction (hydrolysates, cheap growth factors, high cell density) is so critical.
All commercial cultured meat now uses serum-free media — no current-paradigm cost trajectory depends on fetal bovine serum (FBS).
Historical note: why the industry moved to serum-free (click to expand)
Until ~2018, animal cell culture relied on fetal bovine serum ($200–1,000/L), a complex mixture collected from bovine fetuses at slaughter. FBS was the universal cell-culture supplement — used across chicken, cow, pig, and fish work — because it contains hundreds of beneficial proteins (growth factors, albumin, attachment proteins, hormones).
It was abandoned for cultured meat for three reasons that all point the same direction:
It can’t scale. Global FBS supply is ~500,000–800,000 L/yr (van der Valk et al. 2018). At ~100 mL FBS per kg of meat (10% supplementation), 1 Mt of cultured meat would need ~100 billion L/yr — roughly 200,000× existing supply.
It contradicts the welfare goal. FBS is collected from bovine fetuses when pregnant cows are slaughtered (~1M+ fetuses/yr per PMC 2014).
It’s expensive and inconsistent. Batch-to-batch variability and $200–1,000/L pricing make it unworkable for commodity production.
All approved cultured meat products to date (UPSIDE Foods, GOOD Meat) use serum-free formulations. For cost modeling, FBS should be treated as historical context, not a current cost line.
Hydrolysates: The Big Win for Amino Acids
Hydrolysates are enzymatically digested proteins from plants (soy, wheat) or yeast. They replace the amino acid fraction of media — typically 30-50% of media cost — and provide complete amino acid profiles at food-grade prices:
Believer Meats, the company behind the Pasitka et al. 2024 chicken-specific TEA, shut down operations in late 2025. This is worth noting because their study provides some of the most optimistic (and the only chicken-specific) cost estimates in the literature. The shutdown likely reflects a combination of factors — capital constraints during the 2023-2025 VC pullback from alt-protein, timeline/investor mismatch, and possibly scale-up challenges — rather than a direct falsification of their published engineering estimates. We treat their technical results as still informative but factor the shutdown into our uncertainty about near-term achievability of their projected costs. See the TEA comparison page for more context.
How Does $/L Convert to $/kg Meat? (click to expand)
To convert media cost per liter to cost per kg of meat, you need to know the cell density:
\[\text{Media cost per kg} = \frac{\text{Media cost per L} \times 1000}{\text{Cell density (g/L)}}\]
Cell Density
Media at $1/L
Media at $0.50/L
50 g/L
$20/kg meat
$10/kg meat
100 g/L
$10/kg meat
$5/kg meat
200 g/L
$5/kg meat
$2.50/kg meat
This is why cell density is so important — it’s the denominator that determines how much media you need per kg of output.
Note: Hydrolysate-based and pharma-grade media can achieve comparable cell densities in published studies, though hydrolysate performance can vary depending on source, lot, and formulation. The cost difference is substantial, but performance equivalence should not be assumed across all cell types and conditions without validation.
Tip
Hydrolysates are a promising and widely-pursued cost reduction pathway. Per Humbird 2021: “Soybean meal pricing for animal feed is about $0.33/kg… a formulation of mixed amino acids from hydrolysis could cost as little as $1.60/kg.” At $2/kg hydrolysate, “the macronutrient contribution [is reduced] by almost $16/kg, bringing the total cost to $22/kg.” Multiple studies have validated hydrolysate use for muscle cell culture (Ahmad et al. 2023, Ng & Zheng 2024), and several companies report achieving hydrolysate-based media at $1/L or less.1
Step 5: Growth Factors — A Key Cost Driver
Estimated cost share: ~2-40% of total production cost (wide range — depends heavily on technology breakthroughs)
What Are Growth Factors?
Growth factors are signaling proteins that tell cells to proliferate and differentiate. They bind to cell surface receptors and trigger intracellular cascades:
Mechanism in one sentence: a growth factor protein binds a cell-surface receptor → intracellular signal cascade → gene expression telling the cell to divide. The SVG illustrating this was removed from this page in the Apr 2026 trim — it’s educational but not cost-relevant. (See any cell-biology textbook, or GFI’s growth factor primer.)
Key Growth Factors for Cultured Meat
Why Multiple Growth Factors? (click to expand)
Different growth factors serve different purposes in the cell lifecycle:
FGF-2: Keeps cells proliferating without differentiating (you want lots of cells first)
IGF-1: Promotes growth; also helps trigger differentiation into muscle
TGF-β: Triggers differentiation and ECM production
EGF: Additional proliferation signal
Are they all required? Not necessarily all four — formulations vary. But you typically need at least FGF-2 (for proliferation) and something to trigger differentiation (TGF-β or similar). The exact cocktail depends on cell type and process.
Usage: typically 10-100 ng/mL of each factor, refreshed as media is changed.
Cost/kg meat estimates assume ~50 ng/mL usage concentration and ~20 L media per kg of output (at 50 g/L cell density). At higher densities (100+ g/L), media usage and GF costs per kg drop proportionally.
Why Are They So Expensive?
Current growth factors are produced for medical research markets where volumes are tiny (milligrams), purity requirements are extreme, and customers pay premium prices. Per GFI: “99% cost reduction may be required for some recombinant proteins compared to how they are currently produced for the biopharmaceutical industry.” To hit $10/kg meat with GFs at 10% of cost, “albumin would need to be produced at $10/kg, insulin and transferrin at $1,000/kg, and growth factors at $100,000/kg.”
Solutions Being Developed for All Expensive Growth Factors
The approaches below aim to reduce costs for all the expensive recombinant proteins above (FGF-2, IGF-1, TGF-β, EGF), not just one specific factor. Each approach could in principle produce any protein cheaply at scale.
Growth Factor Costs: A Key Uncertainty (click to expand)
Based on our analysis, growth factor costs appear to be one of the largest uncertainties in cultured meat economics. Here’s our reasoning:
Scenario
GF Cost per kg meat
Total cost impact
Breakthrough (any approach works)
<$1/kg
Likely negligible
Partial success
$5-20/kg
Significant but potentially manageable
Limited progress
$50-100+/kg
Could be prohibitive at scale
Why we frame this as “any one works”: The breakthrough technologies (precision fermentation, plant molecular farming, autocrine cell lines) are largely substitutes. If any one succeeds at scale, the problem is substantially addressed.
This reasoning underlies our model’s binary switch approach — though we acknowledge this is a simplification. Reality may involve partial successes or combinations of approaches.
See GFI’s analysis for detailed technical roadmaps on each approach.
Important caveat: a 2024 Nature Food scoping review of TEAs concluded: “TEAs published to date demonstrate that, under the current technological paradigm, CM is unlikely to be competitive with conventional meat.” However, the review notes that “scale-up feasibility may hinge on cost-saving areas such as use of plant-based media components, food-grade aseptic conditions and extensive scaling of related supply chains.”
Most cheap-GF approaches (autocrine cell lines, precision fermentation, plant molecular farming) involve some form of genetic modification, so jurisdictions that restrict GM inputs may face structurally higher GF costs. Whether and how to fork CM_01 by regulatory environment is being discussed at the workshop.
Step 6: Harvest & Processing
Estimated cost share: 2-15% of total production cost (lower for unstructured products like nuggets)
Cell Harvest
After cells reach target density, they’re separated from the media using standard bioprocessing techniques (Rathore et al. 2020):
Centrifugation: Spin to separate cells (~$0.10-0.50/kg)
Filtration: Tangential flow filtration through membranes
Settling: Allow cells to settle naturally (slowest but cheapest)
Our model includes an optional “downstream processing” toggle that adds $2-15/kg for structured products.
Reality check: Scaffolding in 2026
Industry sources suggest most companies have moved away from scaffolding for first-generation products:
Cannot achieve required cell densities with scaffolds
Most companies targeting unstructured products (mince, nuggets) first
Academic papers continue publishing scaffolding research, but this may not reflect current industry direction
The model’s downstream processing toggle ($2-15/kg for structured products) should be treated as speculative for near-term projections. First commercial products are more likely to be unstructured or blended with plant-based ingredients.
Cost Breakdown Summary
This diagram summarizes the typical cost structure and key levers for reduction, drawing on the components explained above: media, growth factors, bioreactors, and cell density.
Note: Cell density reduces media volume needed per kg, affecting the green (media) cost component. It does not directly relate to micronutrients (teal).
Many foundational TEA analyses in this field date from 2021 (Humbird, Risner et al., CE Delft, GFI). These remain widely cited because they established the analytical frameworks still in use. Where possible, we supplement with more recent data:
The field is evolving rapidly. If you know of newer sources we should cite, please add a Hypothesis comment!
Whether to specify CM_01 by jurisdiction (gene-editing-permissive vs restrictive markets, US vs EU vs Singapore) or stick with a global average is a workshop framing question — see the workshop discussion.
Further Resources
The full prioritized reading list lives on the workshop resources page. Three starting points:
There is some disagreement here. GFI’s 2025 amino acid report notes that hydrolysates can be deficient in key amino acids and typically require supplementation or blending. Humbird (2021) describes hydrolysate suitability as requiring “further study.” We are investigating the latest evidence on this point and welcome feedback.↩︎
Source Code
---title: "How Cultured Chicken is Made"subtitle: "A Deep Dive into Cellular Agriculture Production"toc: trueformat: html: include-after-body: text: | <script src="https://hypothes.is/embed.js" async></script>---::: {.callout-note collapse="true"}## Workshop: Cultured Meat Cost Trajectories (Late April / Early May 2026)This page provides background for [The Unjournal's upcoming expert workshop](https://uj-cm-workshop.netlify.app/) on CM production costs. We're bringing together TEA researchers, evaluators, and stakeholders to assess cost trajectories and identify key uncertainties. [Join us](https://uj-cm-workshop.netlify.app/schedule.html):::```{=html}<style>/* CSS-based instant tooltips for technical terms */abbr[title] { text-decoration: underline dotted #0d6efd; text-underline-offset: 3px; cursor: help; position: relative; font-style: normal;}abbr[title]:hover { text-decoration: underline solid #0d6efd; background-color: #e7f1ff;}/* Instant tooltip that appears on hover */abbr[title]::after { content: attr(title); position: absolute; bottom: 100%; left: 50%; transform: translateX(-50%); background-color: #2c3e50; color: white; padding: 8px 12px; border-radius: 6px; font-size: 13px; line-height: 1.4; white-space: normal; width: max-content; max-width: 300px; z-index: 1000; opacity: 0; visibility: hidden; transition: opacity 0.15s ease-in-out, visibility 0.15s ease-in-out; pointer-events: none; box-shadow: 0 2px 8px rgba(0,0,0,0.2); margin-bottom: 8px; text-align: left; font-weight: normal;}/* Arrow pointing down */abbr[title]::before { content: ""; position: absolute; bottom: 100%; left: 50%; transform: translateX(-50%); border: 6px solid transparent; border-top-color: #2c3e50; margin-bottom: 2px; opacity: 0; visibility: hidden; transition: opacity 0.15s ease-in-out, visibility 0.15s ease-in-out; z-index: 1001;}abbr[title]:hover::after,abbr[title]:hover::before { opacity: 1; visibility: visible;}</style>```::: {.callout-note collapse="true"}## We Want Your FeedbackFor substantive debate on biology, costs, or welfare — please post on [💬 GitHub Discussions](https://github.com/unjournal/cm_pq_modeling/discussions). That's where threaded conversation can get involved, with replies others can reply to and build on. Direct links:- 🧠 [**Substantive hub**](https://github.com/unjournal/cm_pq_modeling/discussions/3) — for biology, economics, engineering, and welfare debate (**the main event**)- 🎯 [PQ framing hub](https://github.com/unjournal/cm_pq_modeling/discussions/4) — for how we *define* the questions (jurisdiction forks, resolution criteria)- 💬 [Workshop hub](https://github.com/unjournal/cm_pq_modeling/discussions/2) — for session prep, agenda, and logistics- 📖 [Full Discussion Map](discuss.html) — the curated indexFor **quick inline notes** on specific text, use [Hypothesis](https://hypothes.is/) (click the `<` tab on the right edge). For anything beyond a brief highlight, prefer GitHub Discussions so the conversation stays organized.:::::: {.callout-tip}**Return to:** [Interactive Cost Model](index.qmd) | **Technical details:** [Documentation](docs.qmd) | **[Audio Review (MP3)](model_review_report.mp3)** | **[Workshop (May 2026)](https://uj-cm-workshop.netlify.app/)**:::## Overview**Cultured chicken** (also called "cell-based" or "cultivated" chicken) is produced by growing <abbr title="Cells from birds (chickens, ducks, etc.) as opposed to mammalian cells from cows or pigs">avian muscle cells</abbr> in <abbr title="Vessels designed for growing cells or microorganisms under controlled conditions (temperature, pH, oxygen, mixing)">bioreactors</abbr> — essentially brewing meat instead of raising and slaughtering animals. Production costs have dropped dramatically — per [GFI](https://gfi.org/science/the-science-of-cultivated-meat/), the first cultured burger in 2013 "took months to produce and was reported to cost $330,000." Today, optimistic projections suggest ~$63/kg ([Garrison et al. 2022](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/)), with some companies claiming costs below $10/kg for pure cell mass (per a [2025 Lever VC industry report](https://www.levervc.com/) — note: authored by CM investors). These are costs for pure cultured cells, not finished consumer products, which may blend CM with plant-based or fungal ingredients at lower overall cost. This page explains the production process in detail and how each step affects costs. To explore these costs interactively, see our [Monte Carlo cost model](index.qmd).::: {.callout-warning}## Cost Basis Matters: Read CarefullyCost figures in the cultivated meat literature refer to different things depending on the study. Throughout this page, we label costs by their **output basis** where known:- **Pure cell mass (wet weight)**: Cost to produce unprocessed cells in a bioreactor — this is what our [dashboard model](index.qmd) estimates- **Cultivated ingredient**: Cell mass after downstream processing (washing, concentration)- **Hybrid product**: A blend of cultivated cells with plant-based or other ingredients (e.g., 50/50 cultivated/plant-based)- **Retail-equivalent product**: Final consumer product including packaging, distribution, marginsA $14/kg figure for pure cell mass and a $14/kg figure for a 50/50 hybrid imply very different costs for the cultivated component. We try to flag the basis for every number cited below. See our [TEA comparison page](compare.qmd) for a systematic breakdown.:::*The diagram below shows the high-level production flow. Each term is explained in detail in the sections that follow: [Cell Bank](#step-1-cell-banking) → [**<abbr title="Seed Train = the sequence of progressively larger vessels used to expand cells from a tiny frozen vial (~1 mL) up to production scale (1,000+ L). Like growing a starter culture for sourdough bread, but scaling up by 10x at each step.">Seed Train</abbr>**](#step-2-seed-train-scale-up) → [Production](#step-3-production-bioreactors) → [Harvest](#step-6-harvest--processing) → Processing → Product.*```{=html}<svg viewBox="0 0 900 180" style="width: 100%; max-width: 1100px; min-height: 300px; margin: 2rem auto; display: block;"> <!-- Background --> <rect width="900" height="180" fill="#f8f9fa" rx="8"/> <!-- Step 1: Cell Bank --> <g transform="translate(50, 40)"> <circle cx="40" cy="40" r="35" fill="#3498db" opacity="0.2" stroke="#3498db" stroke-width="2"/> <circle cx="40" cy="40" r="8" fill="#3498db"/> <text x="40" y="100" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Cell Banking</text> <text x="40" y="115" text-anchor="middle" font-size="10" fill="#7f8c8d">Frozen starter</text> <text x="40" y="128" text-anchor="middle" font-size="10" fill="#7f8c8d">cells</text> </g> <!-- Arrow 1 --> <path d="M130 80 L170 80" stroke="#bdc3c7" stroke-width="3" marker-end="url(#arrowhead)"/> <!-- Step 2: Seed Train --> <g transform="translate(180, 40)"> <ellipse cx="50" cy="40" rx="45" ry="35" fill="#9b59b6" opacity="0.2" stroke="#9b59b6" stroke-width="2"/> <circle cx="35" cy="35" r="6" fill="#9b59b6"/> <circle cx="50" cy="45" r="6" fill="#9b59b6"/> <circle cx="65" cy="35" r="6" fill="#9b59b6"/> <text x="50" y="100" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Seed Train</text> <text x="50" y="115" text-anchor="middle" font-size="10" fill="#7f8c8d">Scale up in</text> <text x="50" y="128" text-anchor="middle" font-size="10" fill="#7f8c8d">small reactors</text> </g> <!-- Arrow 2 --> <path d="M280 80 L320 80" stroke="#bdc3c7" stroke-width="3" marker-end="url(#arrowhead)"/> <!-- Step 3: Production --> <g transform="translate(330, 25)"> <rect x="10" y="15" width="90" height="70" rx="10" fill="#27ae60" opacity="0.2" stroke="#27ae60" stroke-width="2"/> <circle cx="35" cy="40" r="5" fill="#27ae60"/> <circle cx="55" cy="35" r="5" fill="#27ae60"/> <circle cx="75" cy="45" r="5" fill="#27ae60"/> <circle cx="45" cy="55" r="5" fill="#27ae60"/> <circle cx="65" cy="60" r="5" fill="#27ae60"/> <text x="55" y="115" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Production</text> <text x="55" y="130" text-anchor="middle" font-size="10" fill="#7f8c8d">Large bioreactors</text> </g> <!-- Arrow 3 --> <path d="M440 80 L480 80" stroke="#bdc3c7" stroke-width="3" marker-end="url(#arrowhead)"/> <!-- Step 4: Harvest --> <g transform="translate(490, 40)"> <rect x="10" y="10" width="80" height="60" rx="5" fill="#f39c12" opacity="0.2" stroke="#f39c12" stroke-width="2"/> <line x1="20" y1="25" x2="80" y2="25" stroke="#f39c12" stroke-width="2"/> <line x1="20" y1="40" x2="80" y2="40" stroke="#f39c12" stroke-width="2"/> <line x1="20" y1="55" x2="80" y2="55" stroke="#f39c12" stroke-width="2"/> <text x="50" y="100" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Harvest</text> <text x="50" y="115" text-anchor="middle" font-size="10" fill="#7f8c8d">Separate cells</text> <text x="50" y="128" text-anchor="middle" font-size="10" fill="#7f8c8d">from media</text> </g> <!-- Arrow 4 --> <path d="M590 80 L630 80" stroke="#bdc3c7" stroke-width="3" marker-end="url(#arrowhead)"/> <!-- Step 5: Processing --> <g transform="translate(640, 40)"> <rect x="10" y="10" width="80" height="60" rx="5" fill="#e74c3c" opacity="0.2" stroke="#e74c3c" stroke-width="2"/> <rect x="25" y="25" width="50" height="30" rx="3" fill="#e74c3c" opacity="0.5"/> <text x="50" y="100" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Processing</text> <text x="50" y="115" text-anchor="middle" font-size="10" fill="#7f8c8d">Form into</text> <text x="50" y="128" text-anchor="middle" font-size="10" fill="#7f8c8d">products</text> </g> <!-- Arrow 5 --> <path d="M740 80 L780 80" stroke="#bdc3c7" stroke-width="3" marker-end="url(#arrowhead)"/> <!-- Final: Product (chicken breast shape) --> <g transform="translate(790, 40)"> <rect x="10" y="15" width="60" height="50" rx="8" fill="#2ecc71" stroke="#27ae60" stroke-width="2"/> <text x="40" y="48" text-anchor="middle" font-size="18" fill="white">🍗</text> <text x="40" y="100" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Chicken</text> </g> <!-- Arrowhead marker --> <defs> <marker id="arrowhead" markerWidth="10" markerHeight="7" refX="9" refY="3.5" orient="auto"> <polygon points="0 0, 10 3.5, 0 7" fill="#bdc3c7"/> </marker> </defs></svg>```---## Why Chicken?Several factors make chicken an attractive first target for cultured meat:| Factor | Advantage | Source ||--------|-----------|--------|| **Cell biology** | Chicken <abbr title="Muscle stem cells that can differentiate into mature muscle fibers; named for their position adjacent to muscle fibers">satellite cells</abbr> can be cultured effectively and show <abbr title="Cells remain healthy, continue growing well, and maintain their function under culture conditions">robust viability</abbr> | [<abbr title="'Efficient production of chicken satellite cell-based meat: Optimized culture medium, cell seeding density, and harvest time' — demonstrates optimized culture conditions for chicken satellite cells including serum-free proliferation and differentiation.">Kim et al. 2024</abbr>](https://pmc.ncbi.nlm.nih.gov/articles/PMC11506350/) || **Spontaneous immortalization** | <abbr title="Per Pasitka et al. 2022: 'HUN-CF-2 cell line exhibited stable cell growth for over 300 population doublings' without genetic modification. Cells reached 'densities of 108 × 10⁶ cells per ml' in serum-free suspension culture.">Some avian cells can divide indefinitely without genetic modification</abbr> — a rare natural trait that avoids <abbr title="Genetically Modified Organism — cells or organisms whose DNA has been altered using genetic engineering">GMO</abbr> concerns | [<abbr title="'Spontaneously immortalized chicken fibroblasts generate an osteochondral-like tissue' (Nature Food, 2022). Key finding: chicken fibroblast cell line HUN-CF-2 grew for 300+ population doublings without genetic modification, in serum-free suspension culture at densities of 108 million cells/mL. Supports the claim that avian cells can naturally immortalize.">Pasitka et al. 2022</abbr>](https://www.nature.com/articles/s43016-022-00658-w) || **Market size** | Chicken is the most consumed meat globally (~130 million tonnes/year) | [FAO 2023](https://www.fao.org/faostat/en/#data/QCL) || **Animal welfare** | <abbr title="Because chickens are much smaller than cattle, far more individual animals are killed for the same amount of meat. From an animal welfare perspective, replacing chicken production could reduce the largest number of individual animal lives affected. See Rethink Priorities and Open Philanthropy analyses of farmed animal suffering.">~70 billion chickens slaughtered annually</abbr> vs ~300 million cattle | [FAO 2023](https://www.fao.org/faostat/en/#data/QCL), [Rethink Priorities](https://rethinkpriorities.org/research/animal-welfare) || **Growth factors** | <abbr title="Why this matters: since chicken cells need similar growth factors at similar concentrations as bovine cells, the same cost-reduction technologies (precision fermentation, plant molecular farming) being developed for beef will also work for chicken. This means chicken benefits from all the R&D investment targeting bovine cultured meat.">Similar</abbr> <abbr title="Fibroblast Growth Factor 2 — stimulates cell proliferation and maintains stem cell properties">FGF-2</abbr>/<abbr title="Insulin-like Growth Factor 1 — promotes cell growth and differentiation">IGF-1</abbr> requirements to bovine (~10-100 <abbr title="nanograms per milliliter — a very small concentration. One nanogram = one billionth of a gram. At these tiny concentrations, even expensive growth factors contribute modest cost per liter of media.">ng/mL</abbr> optimal) | [Ahmad et al. 2023](https://pmc.ncbi.nlm.nih.gov/articles/PMC10119461/) |---## Step 1: Cell Banking<span style="background: #e8f5e9; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Per Humbird 2021: cell banking is a one-time setup cost amortized over many production runs. At 20 kTA scale, the per-kg contribution is negligible — well under $0.10/kg vs. $37/kg total. Risner et al. 2021 and GFI (2020) do not itemize it separately, treating it as part of overhead."><1% of total production cost at scale</abbr>**</span>### What HappensA **cell bank** is a frozen inventory of starter cells that can be thawed and expanded for production. These cells are taken from a living animal (via <abbr title="A small tissue sample taken from a living animal — typically just a few milligrams, causing minimal harm">biopsy</abbr>) or from <abbr title="A population of cells derived from a single cell that can grow indefinitely in culture">cell lines</abbr> that have been <abbr title="Modified (naturally or artificially) to divide indefinitely, bypassing normal cell aging limits">immortalized</abbr> for continuous growth. Cell banking follows <abbr title="Per Baust et al. 2016 (Biopreservation and Biobanking): 'A well-characterized cell bank provides a consistent, reproducible starting material... master and working cell bank systems are standard practice in biopharmaceutical manufacturing.'">standard biopharmaceutical protocols</abbr> for master and working cell banks ([Baust et al. 2016](https://doi.org/10.1089/bio.2015.0104), [GFI Technical Overview](https://gfi.org/science/the-science-of-cultivated-meat/)).*The diagram below shows the four steps of cell banking: (1) take a small biopsy from a living animal; (2) **isolate cells** — a tissue sample contains many cell types tangled together, so we use <abbr title="Enzymatic digestion uses enzymes (like trypsin or collagenase) to break down the connective tissue holding cells together, releasing individual cells into a liquid suspension. Think of it like dissolving the glue between bricks to free each brick separately.">enzymatic digestion</abbr> to separate individual cells from the tissue matrix; (3) expand the isolated cells by growing them in culture; (4) freeze them via <abbr title="Cryopreservation = freezing cells at -196°C in liquid nitrogen with a cryoprotectant (like DMSO) that prevents ice crystals from damaging cells. Properly frozen cells can remain viable for decades.">cryopreservation</abbr> (-196°C) for long-term storage.*```{=html}<svg viewBox="0 0 600 200" style="width: 100%; max-width: 800px; min-height: 280px; margin: 1.5rem auto; display: block;"> <rect width="600" height="200" fill="#f0f4f8" rx="8"/> <!-- Biopsy --> <g transform="translate(30, 30)"> <text x="50" y="0" text-anchor="middle" font-size="11" font-weight="bold" fill="#2c3e50">1. Biopsy</text> <ellipse cx="50" cy="50" rx="40" ry="30" fill="#f5deb3" stroke="#8b4513" stroke-width="2"/> <circle cx="50" cy="50" r="10" fill="#e74c3c" opacity="0.7"/> <text x="50" y="100" text-anchor="middle" font-size="9" fill="#7f8c8d">Small tissue</text> <text x="50" y="112" text-anchor="middle" font-size="9" fill="#7f8c8d">sample from</text> <text x="50" y="124" text-anchor="middle" font-size="9" fill="#7f8c8d">live animal</text> </g> <path d="M130 70 L170 70" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr2)"/> <!-- Isolation --> <g transform="translate(180, 30)"> <text x="50" y="0" text-anchor="middle" font-size="11" font-weight="bold" fill="#2c3e50">2. Isolate Cells</text> <rect x="20" y="20" width="60" height="60" rx="5" fill="#ecf0f1" stroke="#3498db" stroke-width="2"/> <circle cx="35" cy="45" r="6" fill="#e74c3c"/> <circle cx="50" cy="55" r="6" fill="#e74c3c"/> <circle cx="65" cy="42" r="6" fill="#e74c3c"/> <text x="50" y="100" text-anchor="middle" font-size="9" fill="#7f8c8d">Enzymatic</text> <text x="50" y="112" text-anchor="middle" font-size="9" fill="#7f8c8d">digestion</text> </g> <path d="M280 70 L320 70" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr2)"/> <!-- Expansion --> <g transform="translate(330, 30)"> <text x="50" y="0" text-anchor="middle" font-size="11" font-weight="bold" fill="#2c3e50">3. Expand</text> <rect x="10" y="20" width="80" height="60" rx="5" fill="#ecf0f1" stroke="#27ae60" stroke-width="2"/> <circle cx="25" cy="40" r="5" fill="#e74c3c"/> <circle cx="40" cy="50" r="5" fill="#e74c3c"/> <circle cx="55" cy="38" r="5" fill="#e74c3c"/> <circle cx="70" cy="55" r="5" fill="#e74c3c"/> <circle cx="35" cy="65" r="5" fill="#e74c3c"/> <circle cx="60" cy="68" r="5" fill="#e74c3c"/> <text x="50" y="100" text-anchor="middle" font-size="9" fill="#7f8c8d">Grow to</text> <text x="50" y="112" text-anchor="middle" font-size="9" fill="#7f8c8d">billions</text> </g> <path d="M430 70 L470 70" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr2)"/> <!-- Freeze --> <g transform="translate(480, 30)"> <text x="50" y="0" text-anchor="middle" font-size="11" font-weight="bold" fill="#2c3e50">4. Freeze</text> <rect x="25" y="20" width="50" height="70" rx="3" fill="#3498db" opacity="0.3" stroke="#2980b9" stroke-width="2"/> <rect x="32" y="30" width="36" height="12" rx="2" fill="#ecf0f1" stroke="#7f8c8d"/> <rect x="32" y="48" width="36" height="12" rx="2" fill="#ecf0f1" stroke="#7f8c8d"/> <rect x="32" y="66" width="36" height="12" rx="2" fill="#ecf0f1" stroke="#7f8c8d"/> <text x="50" y="110" text-anchor="middle" font-size="9" fill="#7f8c8d">-196°C in</text> <text x="50" y="122" text-anchor="middle" font-size="9" fill="#7f8c8d">liquid nitrogen</text> </g> <defs> <marker id="arr2" markerWidth="8" markerHeight="6" refX="7" refY="3" orient="auto"> <polygon points="0 0, 8 3, 0 6" fill="#bdc3c7"/> </marker> </defs></svg>```### Cell Types Used| Cell Type | Description | Pros | Cons | Source ||-----------|-------------|------|------|--------|| **Satellite cells** (<abbr title="Precursor cells that will become muscle cells (myocytes)">myoblasts</abbr>) | Muscle stem cells that <abbr title="The process of a stem cell becoming a specialized cell type (e.g., muscle fiber)">differentiate</abbr> into muscle fibers | Natural muscle tissue, good texture | Limited doublings (~50-80 before <abbr title="Cellular aging — cells lose the ability to divide and eventually die">senescence</abbr>) | [Ding et al. 2018](https://www.nature.com/articles/s41598-018-28746-7) || **Immortalized lines** | Cells modified to divide indefinitely | Consistent, scalable, no senescence | Regulatory complexity, <abbr title="Genetically Modified Organism — may require special labeling and regulatory approval">GMO</abbr> perception | [Pasitka et al. 2022](https://www.nature.com/articles/s43016-022-00658-w) || **<abbr title="Induced Pluripotent Stem Cells — adult cells reprogrammed to behave like embryonic stem cells">iPSCs</abbr>** | Induced <abbr title="Pluripotent = able to become many different cell types (muscle, fat, bone, etc.). These are adult cells reprogrammed back to an embryonic-like state so they can differentiate into whatever cell type is needed.">pluripotent</abbr> stem cells | Can become any cell type | <abbr title="Differentiation protocols are the specific sequences of growth factors, timing, and culture conditions needed to guide pluripotent cells into becoming a desired cell type (e.g., muscle). These are complex because they must precisely mimic natural developmental signals.">Complex differentiation protocols</abbr> | [Choi et al. 2022](https://pmc.ncbi.nlm.nih.gov/articles/PMC9686897/) |### Cost ImpactCell banking is a one-time setup cost that's <abbr title="Spread out over all the production runs that use cells from that bank — like spreading the cost of building a factory over all products made in it">amortized</abbr> over many production runs.::: {.callout-tip collapse="true"}## How Cell Banking Costs Work (click to expand)Think of it like this:- **Initial cost**: $50K-$500K to establish and characterize a cell bank- **Cells produced**: Billions of cells per vial, hundreds of vials per bank- **Production supported**: Each bank can support **thousands of production batches**If a bank costs $200K and supports 10,000 batches of 1,000 kg each, the per-kg cost is: $200K ÷ 10M kg = **$0.02/kg**This is negligible compared to media costs ($5-50/kg) and CAPEX ($2-10/kg). Cell banking typically represents **<1% of total production cost** at scale.The cells aren't "used up" in the traditional sense — each frozen vial is thawed and expanded by ~10 billion-fold before production. The bank only needs replacement when vials run out or cells lose performance.:::A well-characterized cell bank can support years of production ([GFI 2021](https://gfi.org/science/the-science-of-cultivated-meat/)).::: {.callout-note collapse="true"}## Why the Hayflick Limit Matters (click to expand)The **<abbr title="Per Hayflick 1961: 'normal human fetal cell population will divide between 40 and 60 times in cell culture before entering a senescence phase.' Primary fibroblasts undergo 'PD 50 ± 10' before stopping.">Hayflick limit</abbr>** (doubling limit) of cells matters for cell banking logistics and cost, though the per-kg impact at scale is small (<1% of total):- **Primary satellite cells** can only double ~50-80 times before <abbr title="Per Nature 2025: 'reduction of differentiation capacity in myoblasts, unfortunately, precedes replicative senescence' — cells lose function before hitting the doubling limit">senescing</abbr> ([Hayflick 1965](https://pubmed.ncbi.nlm.nih.gov/14315085/), [Nature 2025](https://www.nature.com/articles/s42003-025-09180-8))- This means you need **frequent cell bank renewals** (new biopsies, characterization, validation)- **Immortalized lines** eliminate this constraint — one cell bank can theoretically last forever- Trade-off: Immortalized cells may require GMO labeling and face regulatory scrutinyCost implication: If a cell line can produce 10× more batches before replacement, your per-batch cell banking cost drops by 10×.:::---## Step 2: Seed Train (Scale-Up)<span style="background: #e8f5e9; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Seed train costs are primarily labor and media for the small-volume expansion steps. Per Humbird 2021: seed train bioreactors are a small fraction of total CAPEX (~$2M of $34M production bioreactor cost), and media volumes are orders of magnitude smaller than production. Typically estimated at 5-10% of total cost, mostly from labor time.">~5-10% of total production cost</abbr>** (mostly labor)</span>### What HappensCells are progressively expanded from small flasks to larger and larger bioreactors, typically increasing volume by ~10× at each step:*The diagram shows the typical progression: vial → T-flask (flat bottle for early culture) → spinner flask (small stirred vessel) → progressively larger bioreactors. Cell counts grow from millions (10⁶) to hundreds of billions (10¹¹+). Timeline shows typical days in culture.*```{=html}<svg viewBox="0 0 700 240" style="width: 100%; max-width: 900px; min-height: 320px; margin: 1.5rem auto; display: block;"> <rect width="700" height="240" fill="#f8f9fa" rx="8"/> <!-- Title --> <text x="350" y="25" text-anchor="middle" font-size="14" font-weight="bold" fill="#2c3e50">Seed Train: Progressive Scale-Up</text> <!-- Vial --> <g transform="translate(30, 50)"> <rect x="25" y="20" width="20" height="50" rx="3" fill="#ecf0f1" stroke="#3498db" stroke-width="2"/> <rect x="28" y="45" width="14" height="20" fill="#e74c3c" opacity="0.6"/> <text x="35" y="90" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">Vial</text> <text x="35" y="105" text-anchor="middle" font-size="9" fill="#7f8c8d">1 mL</text> <text x="35" y="118" text-anchor="middle" font-size="9" fill="#3498db">10⁶ cells</text> </g> <path d="M85 85 L110 85" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr3)"/> <!-- T-Flask --> <g transform="translate(115, 50)"> <rect x="10" y="30" width="50" height="35" rx="2" fill="#ecf0f1" stroke="#3498db" stroke-width="2"/> <rect x="25" y="10" width="20" height="25" fill="#ecf0f1" stroke="#3498db" stroke-width="2"/> <rect x="12" y="45" width="46" height="15" fill="#e74c3c" opacity="0.6"/> <text x="35" y="90" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">T-Flask</text> <text x="35" y="105" text-anchor="middle" font-size="9" fill="#7f8c8d">100 mL</text> <text x="35" y="118" text-anchor="middle" font-size="9" fill="#3498db">10⁷ cells</text> </g> <path d="M180 85 L210 85" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr3)"/> <!-- Spinner --> <g transform="translate(215, 45)"> <ellipse cx="45" cy="55" rx="35" ry="30" fill="#ecf0f1" stroke="#9b59b6" stroke-width="2"/> <rect x="40" y="15" width="10" height="25" fill="#9b59b6"/> <ellipse cx="45" cy="60" rx="25" ry="18" fill="#e74c3c" opacity="0.5"/> <text x="45" y="100" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">Spinner</text> <text x="45" y="115" text-anchor="middle" font-size="9" fill="#7f8c8d">1 L</text> <text x="45" y="128" text-anchor="middle" font-size="9" fill="#9b59b6">10⁸ cells</text> </g> <path d="M305 85 L335 85" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr3)"/> <!-- 10L Reactor --> <g transform="translate(340, 35)"> <rect x="15" y="20" width="60" height="70" rx="8" fill="#ecf0f1" stroke="#27ae60" stroke-width="2"/> <rect x="35" y="5" width="20" height="20" fill="#27ae60"/> <rect x="20" y="55" width="50" height="30" fill="#e74c3c" opacity="0.5"/> <text x="45" y="115" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">Small Reactor</text> <text x="45" y="130" text-anchor="middle" font-size="9" fill="#7f8c8d">10 L</text> <text x="45" y="143" text-anchor="middle" font-size="9" fill="#27ae60">10⁹ cells</text> </g> <path d="M430 85 L460 85" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr3)"/> <!-- 100L Reactor --> <g transform="translate(465, 25)"> <rect x="10" y="15" width="80" height="90" rx="10" fill="#ecf0f1" stroke="#f39c12" stroke-width="2"/> <rect x="40" y="0" width="20" height="20" fill="#f39c12"/> <rect x="15" y="60" width="70" height="40" fill="#e74c3c" opacity="0.5"/> <text x="50" y="125" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">Medium Reactor</text> <text x="50" y="140" text-anchor="middle" font-size="9" fill="#7f8c8d">100 L</text> <text x="50" y="153" text-anchor="middle" font-size="9" fill="#f39c12">10¹⁰ cells</text> </g> <path d="M560 85 L590 85" stroke="#bdc3c7" stroke-width="2" marker-end="url(#arr3)"/> <!-- Production Reactor --> <g transform="translate(595, 15)"> <rect x="5" y="10" width="90" height="110" rx="12" fill="#ecf0f1" stroke="#e74c3c" stroke-width="3"/> <rect x="40" y="0" width="25" height="15" fill="#e74c3c"/> <rect x="12" y="60" width="76" height="55" fill="#e74c3c" opacity="0.5"/> <text x="50" y="140" text-anchor="middle" font-size="10" font-weight="bold" fill="#2c3e50">Production</text> <text x="50" y="155" text-anchor="middle" font-size="9" fill="#7f8c8d">1,000+ L</text> <text x="50" y="168" text-anchor="middle" font-size="9" fill="#e74c3c">10¹¹+ cells</text> </g> <!-- Timeline --> <text x="35" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 0</text> <text x="150" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 3</text> <text x="260" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 6</text> <text x="385" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 9</text> <text x="510" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 12</text> <text x="640" y="205" text-anchor="middle" font-size="9" fill="#95a5a6">Day 15+</text> <defs> <marker id="arr3" markerWidth="8" markerHeight="6" refX="7" refY="3" orient="auto"> <polygon points="0 0, 8 3, 0 6" fill="#bdc3c7"/> </marker> </defs></svg>```### Cost ImpactThe <abbr title="The sequence of progressively larger vessels used to expand cells from a small vial to production scale">seed train</abbr> phase typically represents **5-15% of total production cost** at scale. Per [Humbird 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8362201/): at 100 kTA scale, labor costs are "$1/kg wet cell mass" and consumables another "$1/kg":- Uses **expensive, small-scale equipment** (research-grade, often <abbr title="Disposable plastic bioreactor bags/vessels — avoid cleaning validation but add consumable costs">single-use</abbr>)- Requires **manual handling** and skilled labor ($50-150/hour <abbr title="'Fully loaded' = total employer cost including salary plus benefits, payroll taxes, insurance, training, and overhead. Per Humbird 2021: '$50,000/y for regular FTEs' with '100% labor burden' = $100k total. Fed-batch needs '95 total FTE'; perfusion needs '132 FTE'.">fully loaded</abbr>)- Consumes **high-quality media** (often <abbr title="Extremely pure, tested for contaminants, with full documentation — required for drug manufacturing but increasingly replaced by food-grade alternatives. Per Humbird 2021: pharma-grade media at $5-20/L; food-grade alternatives at $0.50-2/L (per Lever VC 2025 claims).">pharma-grade</abbr> at $5-20/L, though many companies now use food-grade at $0.50-2/L)::: {.callout-note collapse="true"}## Are Companies Still Using Pharma-Grade? (click to expand)Increasingly, no. While early R&D relied heavily on pharma-grade media and equipment, most companies scaling up have transitioned to food-grade alternatives. Per a [2025 industry report](https://agfundernews.com/humbird-was-spectacularly-wrong-on-cultivated-meat-economics-says-report-as-vow-predicts-it-will-soon-be-unit-margin-positive):- **Media**: "costs $1 per liter or less and several are under $0.50 per liter" — "10-30× cheaper than [Humbird 2021] thought possible"- **Equipment**: Vow built a 20,000L bioreactor "well under $1 million" (80% below off-the-shelf costs)- **Cell density**: Companies achieving "60-90 g/L" vs Humbird's 60 g/L maximum projectionPer the same report, production COGS for cell mass are claimed to be "$10-15/kg, with some leading-edge companies claiming costs below $10/kg" — up to 50% lower than the 2021 projections. *Note: these claims come from a [Lever VC report](https://www.levervc.com/) authored by CM investors and have not been independently verified.*:::::: {.callout-tip collapse="true"}## Why Cell Density is So Important (click to expand)**<abbr title="Grams of cells per liter of media — higher is better for cost efficiency">Cell density</abbr>** is one of the most important parameters for cost:| Density | Media needed for 1 kg meat | Relative media cost | Est. media cost/kg (at $1/L) ||---------|---------------------------|---------------|------|| 30 g/L | 33 liters | 100% (baseline) | ~$33/kg || 100 g/L | 10 liters | 30% | ~$10/kg || 200 g/L | 5 liters | 15% | ~$5/kg |Higher density means:- **Less media** per kg of meat (biggest savings)- **Fewer reactor transfers** in seed train- **Smaller bioreactors** needed for same output- **Lower labor** per kgCurrent densities: 30-50 g/L (batch), 60-90 g/L (commercial per [2025 industry report](https://agfundernews.com/humbird-was-spectacularly-wrong-on-cultivated-meat-economics-says-report-as-vow-predicts-it-will-soon-be-unit-margin-positive)), up to 360 g/L in perfusion ([PMC 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/)):::---## Step 3: Production Bioreactors<span style="background: #fff3e0; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Per Humbird 2021: Bioreactor CAPEX $4/kg + Buildings $3/kg + Rest of plant $5/kg = $12/kg out of ~$37/kg total. CE Delft (2021) estimates CAPEX at 20-30% for a 10 kTA facility. The range depends heavily on whether pharma-grade ($50-500/L) or food-grade ($5-15/L) equipment is used.">15-35% of total production cost</abbr>** (bioreactor CAPEX + buildings)</span>### The Core Technology<abbr title="'Production-scale' means large enough for commercial manufacturing — typically 1,000-20,000+ liters per vessel, with multiple vessels operating in parallel. For context: a 10,000L bioreactor at 100 g/L density produces ~1,000 kg of cell mass per batch. A facility with 24 such reactors running continuously could produce ~10,000 tonnes/year. Compare to 'research scale' (1-10L) or 'pilot scale' (50-500L).">Production-scale</abbr> bioreactors are the heart of cultured meat manufacturing. They must:1. **Maintain sterility** — Any contamination means losing the entire batch (<abbr title="Per Kelley 2009 (mAbs): a contaminated 2,000L bioreactor batch at $100/g product value and 5 g/L titer = ~$1M in lost product alone, plus 'cost of investigations, cost of decontamination, and lost production time.' Per Cytiva: a single bioburden incident can cost '$100K-$1M+' including investigation, facility shutdown, and batch loss. For cultured meat at lower product value, losses are proportionally lower per batch but contamination rates are higher (11.2% average per PMC 2024).">$100K-$1M+ loss per batch in biopharma</abbr>; see [Kelley 2009](https://pubmed.ncbi.nlm.nih.gov/20073004/), [Cytiva](https://www.cytivalifesciences.com/en/us/news-center/cost-and-impact-of-a-bioburden-incident-10001))2. **Supply oxygen** — Cells need O₂ but are <abbr title="The vigorous mixing needed to distribute oxygen can physically tear apart cells. Imagine being inside a blender — that's what aggressive mixing feels like to cells. This creates a trade-off: mix enough to deliver oxygen, but not so much you kill the cells.">shear-sensitive</abbr>3. **Remove CO₂** — <abbr title="Byproducts of cellular respiration that must be removed">Metabolic waste</abbr> that acidifies media4. **Control temperature** — Typically 37°C ± 0.5°C for <abbr title="Cells from mammals like cows, pigs, or mice — chicken cells (avian) can often tolerate slightly different conditions, sometimes up to 39°C">mammalian cells</abbr> (avian cells similar)5. **Provide nutrients** — Via <abbr title="Perfusion = continuously pumping fresh media into the reactor and removing spent media, while retaining the cells inside (using a filter). Think of it like a fish tank with a constant flow of clean water — waste is removed and fresh nutrients arrive continuously, letting cells grow to much higher densities (100-200+ g/L). More complex and media-intensive, but achieves 3-5x higher cell density than batch.">media perfusion</abbr> or <abbr title="Batch feeding = adding all nutrients at the start, letting cells grow until nutrients are depleted, then harvesting everything at once. Simpler to operate but limited to lower cell densities (30-50 g/L) because waste accumulates and nutrients deplete.">batch feeding</abbr> (see [detailed comparison below](#batch-vs.-perfusion-two-operating-modes))*The diagram below shows a standard stirred-tank bioreactor. Key components: the **impeller** (rotating blades that mix the culture), the **sparger** (bubbles oxygen into the media), and ports for adding media and harvesting cells.*```{=html}<svg viewBox="0 0 500 350" style="width: 100%; max-width: 650px; min-height: 450px; margin: 1.5rem auto; display: block;"> <rect width="500" height="350" fill="#f8f9fa" rx="8"/> <!-- Title --> <text x="250" y="25" text-anchor="middle" font-size="14" font-weight="bold" fill="#2c3e50">Stirred-Tank Bioreactor</text> <!-- Main vessel --> <ellipse cx="250" cy="280" rx="100" ry="30" fill="#bdc3c7"/> <rect x="150" y="80" width="200" height="200" fill="#ecf0f1" stroke="#7f8c8d" stroke-width="3"/> <ellipse cx="250" cy="80" rx="100" ry="30" fill="#ecf0f1" stroke="#7f8c8d" stroke-width="3"/> <!-- Media (liquid) --> <rect x="153" y="140" width="194" height="137" fill="#3498db" opacity="0.3"/> <ellipse cx="250" cy="277" rx="97" ry="27" fill="#3498db" opacity="0.3"/> <!-- Cells --> <circle cx="180" cy="200" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="220" cy="180" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="260" cy="220" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="300" cy="190" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="200" cy="240" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="280" cy="250" r="4" fill="#e74c3c" opacity="0.8"/> <circle cx="240" cy="210" r="4" fill="#e74c3c" opacity="0.8"/> <!-- Impeller shaft --> <rect x="245" y="50" width="10" height="180" fill="#7f8c8d"/> <!-- Impeller blades --> <rect x="200" y="200" width="100" height="8" rx="2" fill="#95a5a6"/> <rect x="200" y="160" width="100" height="8" rx="2" fill="#95a5a6"/> <!-- Motor --> <rect x="225" y="35" width="50" height="30" rx="5" fill="#2c3e50"/> <text x="250" y="55" text-anchor="middle" font-size="10" fill="white">Motor</text> <!-- Sparger (air inlet) --> <circle cx="180" cy="260" r="15" fill="none" stroke="#27ae60" stroke-width="2" stroke-dasharray="3,2"/> <circle cx="180" cy="260" r="3" fill="#27ae60"/> <line x1="150" y1="260" x2="167" y2="260" stroke="#27ae60" stroke-width="2"/> <!-- Labels --> <g transform="translate(370, 80)"> <rect x="0" y="0" width="120" height="160" fill="white" opacity="0.9" rx="5"/> <text x="60" y="20" text-anchor="middle" font-size="11" font-weight="bold" fill="#2c3e50">Key Components</text> <circle cx="15" cy="40" r="5" fill="#7f8c8d"/> <text x="25" y="44" font-size="10" fill="#2c3e50">Impeller (mixing)</text> <circle cx="15" cy="65" r="5" fill="#27ae60"/> <text x="25" y="69" font-size="10" fill="#2c3e50">Sparger (O₂ in)</text> <circle cx="15" cy="90" r="5" fill="#3498db" opacity="0.5"/> <text x="25" y="94" font-size="10" fill="#2c3e50">Media</text> <circle cx="15" cy="115" r="5" fill="#e74c3c"/> <text x="25" y="119" font-size="10" fill="#2c3e50">Cells</text> <text x="60" y="145" text-anchor="middle" font-size="9" fill="#7f8c8d">37°C, pH 7.2-7.4</text> </g> <!-- Ports --> <rect x="135" y="100" width="20" height="10" fill="#f39c12"/> <text x="90" y="108" font-size="9" fill="#7f8c8d">Media in →</text> <rect x="135" y="240" width="20" height="10" fill="#9b59b6"/> <text x="80" y="248" font-size="9" fill="#7f8c8d">Harvest →</text></svg>```### Bioreactor TypesDifferent bioreactor designs make different trade-offs between cost, scale, and cell type compatibility. **Most cultured meat R&D currently uses stirred-tank reactors** (the pharmaceutical industry standard), but companies are actively developing custom food-grade designs to reduce costs.::: {.callout-note collapse="true"}## Which Type Will Win? (click to expand)The industry hasn't converged on a single design yet. Key factors:- **Stirred-tank**: Proven, well-understood, but expensive. Used by most companies today.- **Air-lift**: Gentler on cells, potentially cheaper, but less established.- **Packed-bed**: Required for structured products (steaks), but harder to scale.- **Custom food-grade**: Already in use by some companies (e.g., Vow) — the key question is whether sterility can be maintained at scale.Companies like UPSIDE Foods and Believer Meats have built large-scale facilities using modified pharma equipment, while others (Vow, etc.) are now operating custom food-grade bioreactors at substantially lower cost.:::| Type | Description | Scale | Cost Range | Source ||------|-------------|-------|------------|--------|| **<abbr title="Most common design — a motor-driven impeller stirs the culture. Per Humbird 2021: a 20m³ vessel with agitator costs '$330k' bare, '$1.5M' installed (direct cost factor 3.5).">Stirred-tank</abbr>** | Traditional design with <abbr title="A rotating blade or paddle that mixes the culture">impeller</abbr> mixing | 1-20,000 L | $50-500/L (pharma) | [Humbird 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8362201/) || **<abbr title="Rising air bubbles create circulation without mechanical mixing — gentler on cells">Air-lift</abbr>** | Bubbles provide mixing and oxygenation | 1-50,000 L | $30-200/L | [GFI 2021](https://gfi.org/science/the-science-of-cultivated-meat/) || **<abbr title="Cells attach to a 3D scaffold while media flows past — good for structured products">Packed-bed</abbr>** | Cells grow on <abbr title="A 3D structure (like a sponge) that cells can attach to and grow on">scaffolds</abbr>, media flows through | 10-1,000 L | $100-300/L | [Allan et al. 2019](https://www.frontiersin.org/journals/sustainable-food-systems/articles/10.3389/fsufs.2019.00044/full) || **<abbr title="Emerging commercial use — designs inspired by beer/dairy fermentation equipment, adapted for cell culture. Vow (Australia) and others now operating custom food-grade bioreactors.">Custom food-grade</abbr>** | <abbr title="'Designed for food production' means built to food safety standards (like brewing or dairy equipment) rather than pharmaceutical GMP standards. The key difference: pharma equipment requires extensive validation documentation, ultra-precise controls, and 316L stainless steel. Food-grade uses simpler materials and cleaning procedures. The cost savings come from removing pharma-specific requirements, not from the equipment being used for a different food product.">Simplified designs</abbr> <abbr title="Similar to beer brewing or dairy fermentation — large, simple, cheap — but adapted to maintain sterility for cell culture">inspired by food/beverage industry</abbr> | 1,000-100,000 L | $10-50/L (target) | [Risner et al. 2021](https://www.mdpi.com/2304-8158/10/1/3) |::: {.callout-important collapse="true"}## Why Bioreactor Costs Are Pivotal (click to expand)Bioreactor CAPEX accounts for **<abbr title="Per Humbird 2021: Bioreactor CAPEX $4/kg + Buildings $3/kg + Rest of plant $5/kg = $12/kg of ~$37/kg total production cost. This share can be higher (up to 35%) with pharma-grade equipment or lower (15%) with food-grade alternatives. CE Delft (2021) estimates similar ranges at 10 kTA scale.">roughly 15-35% of total production cost at scale</abbr>**, making it a pivotal cost driver. <abbr title="Equipment built to pharmaceutical industry standards — 316L stainless steel, validated cleaning, full documentation. Per PMC 2024: 10,000L stirred systems cost ~$150M; 2,000L perfusion bioreactors cost ~$260M.">Pharma-grade</abbr> stainless steel bioreactors cost $50-500/L installed ([Humbird 2021](https://www.sciencedirect.com/science/article/pii/S2589014X21000026), [PMC 2024](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/)).The opportunity — already being realized: Several companies are now using simplified <abbr title="Equipment designed for food/beverage production — less stringent than pharma but still safe for human consumption">food-grade</abbr> designs (similar to beer brewing at [$5-15/L](https://www.brewersassociation.org/)). Vow (Australia) has built custom food-grade bioreactors at ~80% below pharma costs, and other companies are following suit. If this approach scales successfully, equipment costs could drop by **10x** industry-wide.| Equipment Type | Cost per Liter | Example Industry ||---------------|----------------|------------------|| <abbr title="Per Humbird 2021: 20m³ production vessel = '$1.5M installed'; 24-reactor facility = '$34M' for production bioreactors alone">Pharma-grade bioreactor</abbr> | $50-500/L | Vaccine production || Food-grade fermentation | $10-50/L | Specialty ingredients || Beer brewing tanks | $5-15/L | Craft breweries |Key question: Can cultured meat production maintain sterility and consistency with simpler equipment? This depends on whether the process can tolerate:- Less precise temperature control- Simpler cleaning validation- Lower-grade materials (304 vs 316L stainless)Contamination is a real risk: Per a [2024 industry survey](https://pmc.ncbi.nlm.nih.gov/articles/PMC11681928/), cultivated meat companies reported an average <abbr title="Per PMC 2024: 'Microbiological contamination batch failure rate averaged 11.2% across 11 respondent companies' — higher at commercial scale (19.5% for 6 respondents). Primary vectors: 'improper equipment sterilization' and 'exposure during cell harvest.'">microbiological batch failure rate of 11.2%</abbr> (climbing to 19.5% at commercial scale). Primary contamination vectors included improper equipment sterilization and exposure during cell harvest. By comparison, the biopharmaceutical industry experiences contamination failures in only ~3.2% of batches at commercial facilities. This helps explain why many cultured meat companies have historically relied on pharma-grade equipment, though the trend is shifting: companies like Vow and others are now building custom food-grade bioreactors at substantially lower cost (per a [2025 Lever VC report](https://agfundernews.com/humbird-was-spectacularly-wrong-on-cultivated-meat-economics-says-report-as-vow-predicts-it-will-soon-be-unit-margin-positive), Vow built a 20,000L bioreactor "well under $1 million," 80% below off-the-shelf costs).:::### Batch vs. Perfusion: Two Operating ModesTL;DR: Batch mode (fill, grow, harvest) is simpler and cheaper to operate but limited to ~30-50 g/L cell density. Perfusion mode (continuous fresh media flow) achieves 100-200+ g/L density but costs more in equipment and media volume. The choice maps directly to the <abbr title="Net fresh media consumed per kg of cells, divided by the nominal (1000/density) reactor-fill volume. 1 = batch; >1 = perfusion; <1 = recycling / fed-batch / harvest concentration.">media-use multiplier</abbr> parameter in [our cost model](index.qmd): batch ≈ 1, perfusion ≈ 2–3, media recycling or fed-batch ≈ 0.5–1. Values below 1 are discussed in [the next section](#media-use-mechanisms).::: {.callout-note collapse="true"}## Details: How batch vs. perfusion works (click to expand)The choice of operating mode is not about different bioreactor *types* — it is about how nutrients are delivered and waste removed within the same basic stirred-tank reactor described above. This choice significantly affects achievable cell density and economics.- **<abbr title="Fill the reactor with media, grow cells until nutrients depleted, harvest everything at once">Batch mode</abbr>**: Fill → Grow → Harvest all. Simple but limited density.- **<abbr title="Continuously pump fresh media in while removing spent media, keeping cells at optimal conditions indefinitely">Perfusion mode</abbr>**: Continuous flow of fresh media, removing waste while retaining cells. Complex but much higher density.*The diagram compares these two operating modes side-by-side. Batch mode (left) harvests everything at once; perfusion (right) continuously adds fresh media and removes spent media while retaining cells.*```{=html}<svg viewBox="0 0 650 200" style="width: 100%; max-width: 900px; min-height: 280px; margin: 0.5rem auto; display: block;"> <rect width="650" height="200" fill="#f8f9fa" rx="8"/> <!-- Batch Mode --> <g transform="translate(20, 20)"> <text x="130" y="15" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Batch Mode</text> <!-- Reactor stages --> <rect x="20" y="35" width="50" height="60" rx="5" fill="#ecf0f1" stroke="#3498db" stroke-width="2"/> <rect x="22" y="70" width="46" height="22" fill="#3498db" opacity="0.4"/> <text x="45" y="115" text-anchor="middle" font-size="8" fill="#7f8c8d">Fill</text> <text x="85" y="65" font-size="14" fill="#bdc3c7">→</text> <rect x="100" y="35" width="50" height="60" rx="5" fill="#ecf0f1" stroke="#27ae60" stroke-width="2"/> <rect x="102" y="55" width="46" height="37" fill="#e74c3c" opacity="0.4"/> <text x="125" y="115" text-anchor="middle" font-size="8" fill="#7f8c8d">Grow</text> <text x="165" y="65" font-size="14" fill="#bdc3c7">→</text> <rect x="180" y="35" width="50" height="60" rx="5" fill="#ecf0f1" stroke="#f39c12" stroke-width="2"/> <rect x="182" y="40" width="46" height="52" fill="#e74c3c" opacity="0.6"/> <text x="205" y="115" text-anchor="middle" font-size="8" fill="#7f8c8d">Harvest all</text> <!-- Stats --> <text x="130" y="145" text-anchor="middle" font-size="9" fill="#27ae60">✓ Simple operation</text> <text x="130" y="160" text-anchor="middle" font-size="9" fill="#e74c3c">✗ 30-50 g/L max density</text> <text x="130" y="175" text-anchor="middle" font-size="9" fill="#7f8c8d">5-10 day cycles</text> </g> <!-- Divider --> <line x1="325" y1="30" x2="325" y2="180" stroke="#ddd" stroke-width="2" stroke-dasharray="5,5"/> <!-- Perfusion Mode --> <g transform="translate(340, 20)"> <text x="140" y="15" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Perfusion Mode</text> <!-- Continuous reactor --> <rect x="70" y="35" width="140" height="70" rx="8" fill="#ecf0f1" stroke="#9b59b6" stroke-width="2"/> <rect x="75" y="45" width="130" height="55" fill="#e74c3c" opacity="0.5"/> <!-- Flow arrows --> <path d="M50 70 L70 70" stroke="#3498db" stroke-width="3" marker-end="url(#arr4)"/> <text x="35" y="60" font-size="8" fill="#3498db">Fresh</text> <text x="35" y="72" font-size="8" fill="#3498db">media</text> <path d="M210 55 L235 55" stroke="#f39c12" stroke-width="3" marker-end="url(#arr4)"/> <text x="245" y="50" font-size="8" fill="#f39c12">Spent</text> <text x="245" y="62" font-size="8" fill="#f39c12">media</text> <path d="M210 85 L235 85" stroke="#e74c3c" stroke-width="3" marker-end="url(#arr4)"/> <text x="245" y="80" font-size="8" fill="#e74c3c">Harvest</text> <text x="245" y="92" font-size="8" fill="#e74c3c">cells</text> <!-- Stats --> <text x="140" y="130" text-anchor="middle" font-size="9" fill="#27ae60">✓ 100-200+ g/L density</text> <text x="140" y="145" text-anchor="middle" font-size="9" fill="#27ae60">✓ Continuous production</text> <text x="140" y="160" text-anchor="middle" font-size="9" fill="#e74c3c">✗ Complex operation</text> <text x="140" y="175" text-anchor="middle" font-size="9" fill="#7f8c8d">Higher media usage</text> </g> <defs> <marker id="arr4" markerWidth="8" markerHeight="6" refX="7" refY="3" orient="auto"> <polygon points="0 0, 8 3, 0 6" fill="currentColor"/> </marker> </defs></svg>```The **<abbr title="Net fresh media consumed per kg of cells, divided by the nominal (1000/density) reactor-fill volume">media-use multiplier</abbr>** parameter in [our interactive model](index.qmd) captures this regime, and a few others:- **Multiplier ≈ 1**: Batch mode (one reactor fill per kg of cells)- **Multiplier ≈ 2–3**: Standard perfusion- **Multiplier < 1**: Media recycling, fed-batch with concentrated feeds, or harvest-side cell concentration — see [the three mechanisms below](#media-use-mechanisms)- **Multiplier 5–10**: Heavily media-intensive perfusion (stress-test region, outside our default):::### The media-use multiplier: why values below 1 are physically meaningful {#media-use-mechanisms}::: {.callout-note collapse="true"}## Why a value below 1 is not a typo (click to expand)The cost model computes liters of media per kg of cells as:$$L_{\text{per kg}} = \underbrace{\frac{1000}{\text{density (g/L)}}}_{\text{nominal reactor-fill volume}} \times \underbrace{\text{multiplier}}_{\text{effective fresh-media factor}}$$At 50 g/L density the nominal reactor-fill volume is 20 L/kg — "one reactor filling, containing 1 kg of cells at 50 g/L." At 100 g/L it's 10 L/kg. A multiplier of **1** means you consumed exactly that much fresh media. Values **above 1** are straightforward: perfusion systems continuously flow fresh media through, and over a batch you cumulatively use several reactor volumes. Values **below 1** feel surprising at first but correspond to three very real mechanisms.**1. Media recycling.** Spent media can be filtered (e.g., by tangential flow filtration), depleted nutrients replenished, and fed back into the reactor. If you recover and reuse 50% of your spent media, your net *fresh* media consumption per kg of cells is half the nominal reactor volume — multiplier ≈ **0.5**. Aggressive recycling is cited in GFI's 2025 review as likely necessary for reaching commercially viable cultivated-meat costs.**2. Fed-batch with concentrated feeds.** Instead of flowing large volumes of dilute fresh media through the reactor, you start at a fraction of the working volume with full-strength media and then add small volumes of *concentrated* glucose / amino-acid / buffer solution as cells consume substrate. The total liquid media consumed over the run can be less than one nominal reactor volume, because most of the added mass is dissolved solute rather than water. Industrial microbial fermentation has been run this way for decades; for cultivated meat it maps to multipliers of ≈ **0.6–0.9**.**3. Harvest-side cell concentration.** If cells are concentrated *after* they finish growing — via settling, centrifugation, or filtration — you can extract 1 kg of cells from less media than `1000 / (growth density)` suggests. For example, running the reactor at 50 g/L growth density but harvesting a 200 g/L slurry means you're pulling 1 kg of cells out of 5 L of media, not 20 L. The baseline formula doesn't have a separate knob for harvest concentration, so the multiplier absorbs that correction — values around **0.25–0.5** can appear this way without any recycling or fed-batch logic.### Why the model's default range includes values below 1The [GFI 2023 recombinant-protein report](https://gfi.org/wp-content/uploads/2023/01/GFI-report_Anticipated-growth-factor-and-recombinant-protein-costs-and-volumes-necessary-for-cost-competitive-cultivated-meat_2023-1.pdf) assumes **8–13 L media per kg of meat** as its cost-competitive scenario. Our dashboard lets you push cell density up to ~90 g/L. At 90 g/L:$$\text{nominal L/kg} = \frac{1000}{90} \approx 11.1 \text{ L/kg}$$So to hit the GFI upper bound of 13 L/kg at 90 g/L, you need multiplier ≈ **1.17**. To hit the lower bound of 8 L/kg at 90 g/L, you need multiplier ≈ **0.72**. At a more typical 60 g/L density, the nominal is 16.7 L/kg, and GFI's 8–13 L/kg implies multipliers of **0.48–0.78**. **None of those scenarios are reachable with a floor of 1.0** — no matter how high cell density goes. That's why the model's default sampling range is now **0.5–3.0** rather than the earlier 1–10.Values above 5× remain plausible for heavily media-intensive processes but are no longer part of the default sampled range; treat them as stress tests for pessimistic scenarios.### What this does NOT mean- It does *not* mean less than one reactor-filling's worth of liquid physically entered the vessel. It means less than one nominal reactor-filling-equivalent of fresh media was consumed, once recycling, concentration, and fed-batch feed schedules are all counted as they affect the $/kg cost calculation.- It does *not* mean perfusion systems are being misrepresented — a perfusion reactor with aggressive media recycling can legitimately operate at an overall multiplier below 1 even though its instantaneous media-change rate is above 1.- The model uses a single bundled parameter rather than separate knobs for turnover, recycle fraction, and harvest concentration. That's a simplification; a future revision may split them.:::::: {.callout-tip}## Cell densities have improved dramatically- **100-200 g/L**: Demonstrated in perfusion systems ([Clincke et al. 2013](https://pubmed.ncbi.nlm.nih.gov/23417786/), [Xu et al. 2023](https://doi.org/10.1016/j.tibtech.2022.08.004))- **360 g/L**: Per [PMC 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/): "harvested...cultured fat at 360 g/L" with "1.5 years of continuous culture and over 600 cell divisions"- **1.3 x 10^11^ cells/L**: Believer Meats [2024 study](https://www.nature.com/articles/s43016-024-01022-w) using $0.63/L media, achieving **$6.20/lb** (~$13.67/kg) cultivated chicken:::::: {.callout-note collapse="true"}## Batch vs Perfusion Trade-offs (click to expand)| Factor | Batch Mode | Perfusion Mode ||--------|------------|----------------|| **<abbr title="Per Humbird 2021: 'an O₂-limited cell density of 195 g/L can be achieved at a perfusion rate of 1.0/d' under optimized conditions">Cell density</abbr>** | 30-50 g/L max | 100-200+ g/L || **Media usage** | Lower total volume (multiplier ≈ 1, or ≈ 0.5–0.9 with fed-batch/recycling) | Higher (multiplier ≈ 2–3 standard, up to 5–10 stress-test) || **Equipment** | Simpler | More complex (pumps, filters) || **Contamination risk** | Lower (closed system) | Higher (more connections) || **Cycle time** | 5-10 days | Continuous |*The batch/perfusion distinction is a simplification. In practice, cell density, media-use multiplier, and recycle fraction are interdependent — higher perfusion density may require additional retention devices (e.g., ATF filters), and media recycling can partially decouple the multiplier from fresh media cost. Our [dashboard model](index.qmd) treats density and the media-use multiplier as separate parameters for simplicity, with the multiplier bundling recycling and harvest concentration (see [Media-use mechanisms](#media-use-mechanisms)); see [Technical Reference](docs.qmd#process-intensities) for how these interact in the cost equations.*Per [Humbird 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8362201/): fed-batch achieves **$37/kg wet cell mass** (or $22/kg with hydrolysates), while perfusion costs **$51/kg wet cell mass** due to higher CAPEX ($23/kg capital charge) and consumables (ATF membranes at $16k each, 20 per bioreactor per year). Perfusion's higher density doesn't always offset equipment costs at current scales. Note: Humbird models generic mammalian cells, not chicken specifically.:::---## Media Composition: 40-70% of Total Cost<span style="background: #fce4ec; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Per Humbird 2021: media components total $22/kg (or ~$6/kg with hydrolysates) out of ~$37/kg total. PMC 2024: 'The culture medium represents the most significant cost in CM production, accounting for 55%–95% of total expenses' at current scales, dropping to 40-70% at optimized production scale. Risner et al. 2021 and GFI 2024 report similar ranges.">40-70% of total production cost</abbr>** — the single largest cost component</span>::: {.callout-note collapse="true"}## Why This Isn't a "Step" (click to expand)Media composition isn't sequential — it's used throughout the production process (in seed train and production bioreactors). We cover it separately because understanding media costs is essential for understanding overall economics.:::Cell culture <abbr title="The nutrient-rich liquid that cells grow in — analogous to the blood that nourishes cells in a living animal">media</abbr> contains everything cells need to grow. Below are components ordered by approximate share of total media cost at production scale:| Component | % of Media Cost | Function | Key Cost Driver ||-----------|----------------|----------|-----------------|| **<abbr title="The 20 building blocks of proteins — cells need all of them to grow. Per Humbird 2021: individual amino acids cost '$19/kg' at scale, but 'plant hydrolysate' alternatives reduce this 'by almost $16/kg' to ~$3/kg.">Amino acids</abbr>** | 30-50% | Building blocks for proteins | <abbr title="Per Humbird 2021: individual amino acids = $19/kg; plant hydrolysates = ~$3/kg — a reduction of almost $16/kg">Hydrolysates vs. pharma-grade</abbr> || **<abbr title="Signaling proteins that tell cells to grow and divide. Per Humbird 2021: 'Growth factors only contribute $3–4/kg of wet cell mass at 100 kTA' — but this assumes bulk pricing breakthroughs.">Growth factors</abbr>** | 5-60%* | Signaling proteins (<abbr title="Fibroblast Growth Factor — stimulates cell proliferation. The most expensive single component at research scale (~$50,000/g catalog price).">FGF</abbr>, <abbr title="Insulin-like Growth Factor — promotes cell growth and differentiation into muscle fibers.">IGF</abbr>, <abbr title="Transforming Growth Factor beta — triggers cells to stop dividing and mature into muscle fibers. Among the most expensive growth factors (~$1,000,000/g catalog).">TGF-β</abbr>) | Technology breakthrough? || **Glucose** | 5-15% | Energy source | Commodity (~$0.50/kg) || **Vitamins** | 3-8% | <abbr title="Helper molecules that enzymes need to function">Metabolic cofactors</abbr> | B-complex, etc. || **Lipids** | 2-5% | Cell membrane building | ~$0.10-0.50/L || **Minerals/salts** | 1-3% | Osmotic balance, enzyme function | Cheap (<$0.10/L) |*Components above are listed by approximate share of media cost (largest first). The bottom three (vitamins, lipids, minerals) together account for only ~5-15% of media cost and are already available at commodity prices — they are not significant cost drivers.**Growth factor share varies enormously: at <abbr title="Small-scale R&D using pharma-grade reagents at catalog prices. Per PMC 2024: 'recombinant proteins constitute up to 95% of media expenses' at research scale.">research scale</abbr> GFs can be 55-95% of media cost ([Specht 2020](https://gfi.org/science/the-science-of-cultivated-meat/)). At <abbr title="Large-scale manufacturing with bulk purchasing, optimized formulations, and potential technology breakthroughs. GFI reports companies achieving media costs of $0.20-0.63/L at scale.">production scale</abbr>, projections range from 5-60% depending on technology assumptions — potentially <5% if <abbr title="Precision fermentation, plant molecular farming, or autocrine cell lines. CRISPR-modified cells have shown potential for 'decreasing GF costs by 90%' (PMC 2024).">breakthrough technologies</abbr> succeed. Based on <abbr title="Per PMC 2024: 'recombinant proteins constitute up to 95% of media expenses' at research scale, but multiple cost-reduction approaches (precision fermentation, plant molecular farming, autocrine lines) are in development. The wide range of projections (5-60%) reflects genuine uncertainty about which approaches will succeed and when.">multiple TEA analyses</abbr>, this appears to be **one of the larger uncertainties** in cultured meat economics.::: {.callout-tip collapse="true"}## Media = 40-70% of Total Production Cost (click for breakdown)At production scale, media (including growth factors) typically represents **40-70% of total production cost**. Per [PMC 2024](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/): "The culture medium represents the most significant cost in CM production, accounting for 55%–95% of total expenses" at current scales. At optimized scales, this drops to 40-70% ([Humbird 2021](https://www.sciencedirect.com/science/article/pii/S2589014X21000026), [Risner et al. 2021](https://www.mdpi.com/2304-8158/10/1/3), [GFI 2024](https://gfi.org/resource/cultivated-meat-eggs-and-dairy-state-of-the-industry-report/)).| Cost Component | Share of Total | Humbird 2021 $/kg ||---------------|----------------|-------------------|| **<abbr title="Macronutrients $19/kg + Micronutrients $3/kg = $22/kg, or ~$6/kg with hydrolysates">Media (all components)</abbr>** | 40-70% | $22/kg (or $6 with hydrolysates) || <abbr title="Bioreactor CAPEX $4/kg + Buildings $3/kg + Rest of plant $5/kg = $12/kg">Capital costs (bioreactors)</abbr> | 15-35% | $12/kg || <abbr title="Labor $1/kg + Consumables $1/kg + Utilities $1/kg = $3/kg">Fixed OPEX (labor, overhead)</abbr> | 10-25% | $3/kg || Downstream processing | 2-15% | — |This is why media cost reduction (hydrolysates, cheap growth factors, high cell density) is so critical.:::All commercial cultured meat now uses serum-free media — no current-paradigm cost trajectory depends on fetal bovine serum (FBS).::: {.callout-note collapse="true"}## Historical note: why the industry moved to serum-free (click to expand)Until ~2018, animal cell culture relied on **fetal bovine serum** ($200–1,000/L), a complex mixture collected from bovine fetuses at slaughter. FBS was the universal cell-culture supplement — used across chicken, cow, pig, and fish work — because it contains hundreds of beneficial proteins (growth factors, albumin, attachment proteins, hormones).It was abandoned for cultured meat for three reasons that all point the same direction:- **It can't scale.** Global FBS supply is ~500,000–800,000 L/yr ([van der Valk et al. 2018](https://pubmed.ncbi.nlm.nih.gov/29906528/)). At ~100 mL FBS per kg of meat (10% supplementation), 1 Mt of cultured meat would need ~100 billion L/yr — roughly 200,000× existing supply.- **It contradicts the welfare goal.** FBS is collected from bovine fetuses when pregnant cows are slaughtered (~1M+ fetuses/yr per [PMC 2014](https://pmc.ncbi.nlm.nih.gov/articles/PMC3967615/)).- **It's expensive and inconsistent.** Batch-to-batch variability and $200–1,000/L pricing make it unworkable for commodity production.All approved cultured meat products to date ([UPSIDE Foods](https://www.upsidefoods.com/), [GOOD Meat](https://www.goodmeat.co/)) use serum-free formulations. **For cost modeling, FBS should be treated as historical context, not a current cost line.**:::### Hydrolysates: The Big Win for Amino Acids**<abbr title="Proteins broken down into amino acids and peptides using enzymes — much cheaper than purified individual amino acids. Hydrolysates replace the amino acid component of media, which represents 30-50% of total media cost (or roughly 15-35% of total production cost).">Hydrolysates</abbr>** are enzymatically digested proteins from plants (soy, wheat) or yeast. They replace the amino acid fraction of media — typically **30-50% of media cost** — and provide complete <abbr title="All 20 amino acids needed for protein synthesis, in the right proportions">amino acid profiles</abbr> at food-grade prices:| Media Type | Cost ($/L) | Source ||------------|-----------|--------|| <abbr title="Traditional pharmaceutical-grade media with purified amino acids">Pharma-grade amino acids</abbr> | $1.00 - $4.00 | [Humbird 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8362201/) || <abbr title="Per PMC 2025: Beefy-9 costs ~$36/L; Beefy-R achieves '14-fold cost reduction' to ~$2.57/L">Optimized serum-free (Beefy-R)</abbr> | $2.00 - $4.00 | [PMC 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/) || <abbr title="Per 2024 Believer study: 'animal-free culture medium that cost only $0.63 per litre' supporting 1.3×10¹¹ cells/L density">Hydrolysate-based (optimized)</abbr> | $0.20 - $1.00 | [Believer 2024](https://www.nature.com/articles/s43016-024-01022-w) |::: {.callout-note collapse="true"}## Note on Believer Meats (Pasitka et al. 2024)Believer Meats, the company behind the Pasitka et al. 2024 chicken-specific TEA, shut down operations in late 2025. This is worth noting because their study provides some of the most optimistic (and the only chicken-specific) cost estimates in the literature. The shutdown likely reflects a combination of factors — capital constraints during the 2023-2025 VC pullback from alt-protein, timeline/investor mismatch, and possibly scale-up challenges — rather than a direct falsification of their published engineering estimates. We treat their technical results as still informative but factor the shutdown into our uncertainty about near-term achievability of their projected costs. See the [TEA comparison page](compare.qmd) for more context.:::::: {.callout-note collapse="true"}## How Does $/L Convert to $/kg Meat? (click to expand)To convert media cost per liter to cost per kg of meat, you need to know the **cell density**:$$\text{Media cost per kg} = \frac{\text{Media cost per L} \times 1000}{\text{Cell density (g/L)}}$$| Cell Density | Media at $1/L | Media at $0.50/L ||-------------|---------------|------------------|| 50 g/L | $20/kg meat | $10/kg meat || 100 g/L | $10/kg meat | $5/kg meat || 200 g/L | $5/kg meat | $2.50/kg meat |This is why cell density is so important — it's the denominator that determines how much media you need per kg of output.Note: Hydrolysate-based and pharma-grade media can achieve comparable cell densities in published studies, though hydrolysate performance can vary depending on source, lot, and formulation. The cost difference is substantial, but performance equivalence should not be assumed across all cell types and conditions without validation.:::::: {.callout-tip}Hydrolysates are a promising and widely-pursued cost reduction pathway. Per [Humbird 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8362201/): "Soybean meal pricing for animal feed is about $0.33/kg... a formulation of mixed amino acids from hydrolysis could cost as little as $1.60/kg." At $2/kg hydrolysate, "the macronutrient contribution [is reduced] by almost $16/kg, bringing the total cost to $22/kg." Multiple studies have validated hydrolysate use for muscle cell culture ([Ahmad et al. 2023](https://pmc.ncbi.nlm.nih.gov/articles/PMC10119461/), [Ng & Zheng 2024](https://www.nature.com/articles/s41538-024-00352-0)), and <abbr title="Per a 2025 industry report: companies have achieved media costs '$1 per liter or less' using hydrolysate-based formulations. Believer Meats (Nature Food 2024) published results with $0.63/L media.">several companies report achieving hydrolysate-based media at $1/L or less</abbr>.^[There is some disagreement here. GFI's 2025 amino acid report notes that hydrolysates can be deficient in key amino acids and typically require supplementation or blending. Humbird (2021) describes hydrolysate suitability as requiring "further study." We are investigating the latest evidence on this point and welcome feedback.]:::---## Step 5: Growth Factors — A Key Cost Driver<span style="background: #fce4ec; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Growth factors are a subset of media costs. At research scale, GFs can be 55-95% of media cost (Specht 2020/GFI). At production scale with current technology, GFs are roughly 5-60% of media cost — translating to ~2-40% of total production cost. Per Humbird 2021: 'Growth factors only contribute $3–4/kg of wet cell mass at 100 kTA' (~8-10% of total), but this assumes bulk pricing breakthroughs. Without those breakthroughs, GFs could be the dominant cost.">~2-40% of total production cost</abbr>** (wide range — depends heavily on technology breakthroughs)</span>### What Are Growth Factors?Growth factors are signaling proteins that tell cells to proliferate and differentiate. They bind to cell surface receptors and trigger intracellular cascades:*Mechanism in one sentence: a growth factor protein binds a cell-surface receptor → intracellular signal cascade → gene expression telling the cell to divide. The SVG illustrating this was removed from this page in the Apr 2026 trim — it's educational but not cost-relevant. (See any cell-biology textbook, or [GFI's growth factor primer](https://gfi.org/science/the-science-of-cultivated-meat/).)*### Key Growth Factors for Cultured Meat::: {.callout-note collapse="true"}## Why Multiple Growth Factors? (click to expand)Different growth factors serve different purposes in the cell lifecycle:- **<abbr title="Fibroblast Growth Factor 2 — tells cells to keep dividing while staying 'young'">FGF-2</abbr>**: Keeps cells proliferating without differentiating (you want lots of cells first)- **<abbr title="Insulin-like Growth Factor 1 — promotes both growth and differentiation">IGF-1</abbr>**: Promotes growth; also helps trigger differentiation into muscle- **<abbr title="Transforming Growth Factor beta — triggers cells to mature into muscle fibers">TGF-β</abbr>**: Triggers differentiation and <abbr title="Extracellular matrix — the structural proteins between cells">ECM</abbr> production- **<abbr title="Epidermal Growth Factor — general proliferation signal">EGF</abbr>**: Additional proliferation signalAre they all required? Not necessarily all four — formulations vary. But you typically need *at least* FGF-2 (for proliferation) and something to trigger differentiation (TGF-β or similar). The exact cocktail depends on cell type and process.Usage: typically 10-100 <abbr title="nanograms per milliliter — billionths of a gram per mL">ng/mL</abbr> of each factor, refreshed as media is changed.:::| Factor | Function | <abbr title="Catalog/research-grade prices from suppliers like Sigma-Aldrich, PeproTech, R&D Systems (2024). Bulk production-scale pricing is substantially lower but not publicly available. These catalog prices represent the starting point that must be reduced.">Research Price</abbr> | <abbr title="Estimated cost contribution per kg of cultured meat output at research-grade prices. Assumes ~50 ng/mL usage and ~20 L media per kg meat (at 50 g/L cell density). Actual values vary with formulation and density.">Cost/kg meat (research)</abbr> | <abbr title="Target prices needed for cultured meat to reach cost-competitiveness (~$10-25/kg). Per GFI: 'albumin at $10/kg, insulin and transferrin at $1,000/kg, and growth factors at $100,000/kg.' Some companies report approaching these targets via precision fermentation.">Production Target</abbr> | <abbr title="Estimated cost contribution per kg of cultured meat output at target production prices. Same usage assumptions as research column.">Cost/kg meat (target)</abbr> | Source ||--------|----------|---------------|--------------|--------------|--------------|--------|| **<abbr title="Fibroblast Growth Factor 2, also called basic FGF. At catalog prices ~$2M/g, FGF2 alone can drive production costs to $400K/kg meat (PMC 2024). Halving GF costs could reduce total expenses by up to 10-fold.">FGF-2</abbr>** (bFGF) | <abbr title="Cell division while maintaining stem-like properties">Proliferation, maintain stemness</abbr> | ~$50,000/g | ~$50/kg | $1-10/g | ~$0.001-0.01/kg | [CEN 2023](https://cen.acs.org/food/food-science/Inside-effort-cut-cost-cultivated/101/i33) || **<abbr title="Insulin-like Growth Factor 1">IGF-1</abbr>** | <abbr title="Cell division and maturation into muscle">Proliferation, differentiation</abbr> | ~$10,000/g | ~$10/kg | $1-10/g | ~$0.001-0.01/kg | <abbr title="Based on catalog prices from major suppliers (Sigma-Aldrich, PeproTech, R&D Systems) as of 2024. Research-grade pricing; bulk pricing is substantially lower but not publicly available.">Market data</abbr> || **<abbr title="Transforming Growth Factor beta">TGF-β</abbr>** | <abbr title="Maturation into muscle fibers and structural protein production">Differentiation, ECM production</abbr> | ~$1,000,000/g | ~$1,000/kg | $10-100/g | ~$0.01-0.10/kg | [GFI 2021](https://gfi.org/science/the-science-of-cultivated-meat/) || **<abbr title="Epidermal Growth Factor">EGF</abbr>** | <abbr title="General cell division signal">Proliferation</abbr> | ~$5,000/g | ~$5/kg | $1-10/g | ~$0.001-0.01/kg | <abbr title="Based on catalog prices from major suppliers (Sigma-Aldrich, PeproTech) as of 2024. Research-grade pricing.">Market data</abbr> |*Cost/kg meat estimates assume ~50 ng/mL usage concentration and ~20 L media per kg of output (at 50 g/L cell density). At higher densities (100+ g/L), media usage and GF costs per kg drop proportionally.*### Why Are They So Expensive?Current growth factors are produced for medical research markets where volumes are tiny (milligrams), purity requirements are extreme, and customers pay premium prices. Per [GFI](https://gfi.org/resource/cultivated-meat-growth-factor-volume-and-cost-analysis/): "99% cost reduction may be required for some recombinant proteins compared to how they are currently produced for the biopharmaceutical industry." To hit $10/kg meat with GFs at 10% of cost, "<abbr title="Albumin is a carrier protein — the most abundant protein in blood serum. It is not a growth factor itself but is used in media to stabilize growth factors, transport lipids, and buffer pH. It is needed in much larger quantities than GFs (grams/L vs nanograms/mL).">albumin</abbr> would need to be produced at $10/kg, <abbr title="Insulin and transferrin are supplementary proteins added to serum-free media. Insulin mimics IGF-1 signaling at higher concentrations; transferrin delivers iron to cells. Both are needed at microgram/mL levels — intermediate between bulk nutrients and trace growth factors.">insulin and transferrin</abbr> at $1,000/kg, and growth factors at $100,000/kg."### Solutions Being Developed for All Expensive Growth FactorsThe approaches below aim to reduce costs for all the expensive recombinant proteins above (FGF-2, IGF-1, TGF-β, EGF), not just one specific factor. Each approach could in principle produce any protein cheaply at scale.| Approach | Mechanism | Status | Target Price | Source ||----------|-----------|--------|--------------|--------|| **<abbr title="Using engineered microbes (bacteria, yeast) to produce proteins — same tech used for insulin and cheese enzymes. Per GFI: target is growth factors at '$100,000/kg' (=$100/g) to enable $10/kg meat.">Precision fermentation</abbr>** | E. coli/yeast produce GFs at scale | Scaling up | $10-100/g | [GFI 2024](https://gfi.org/resource/cultivated-meat-growth-factor-volume-and-cost-analysis/) || **<abbr title="Genetically modifying plants to produce proteins in their leaves/seeds — potentially very cheap at scale">Plant molecular farming</abbr>** | Transgenic plants express GFs | Pilots | $1-10/g | [BioBetter](https://www.foodnavigator.com/Article/2022/09/12/biobetter-s-growth-factor-innovation-cuts-cost-of-cultured-meat/) || **<abbr title="Cells engineered to produce their own growth factors — eliminates need to add GFs to media entirely">Autocrine cell lines</abbr>** | Engineer cells to make their own GFs | Proof of concept | ~$0/g | [Stout et al. 2023](https://pmc.ncbi.nlm.nih.gov/articles/PMC10153192/) || **<abbr title="Cheap synthetic chemicals that mimic growth factor signaling — like a key that fits the same lock">Small molecule substitutes</abbr>** | Chemicals that activate GF receptors | Research | <$1/g | [Ahmad et al. 2023](https://pmc.ncbi.nlm.nih.gov/articles/PMC10119461/) || **<abbr title="Modified growth factors that last longer before breaking down — reduces how much you need to add">Thermostable variants</abbr>** | FGF2-G3 with 20-day <abbr title="Time for half the protein to degrade — longer half-life = less frequent dosing needed">half-life</abbr> | Commercial | Reduces usage | [Enantis](https://www.enantis.com/) |::: {.callout-warning collapse="true"}## Growth Factor Costs: A Key Uncertainty (click to expand)Based on our analysis, growth factor costs appear to be one of the largest uncertainties in cultured meat economics. Here's our reasoning:| Scenario | GF Cost per kg meat | Total cost impact ||----------|--------------------|--------------------|| **Breakthrough** (<abbr title="Precision fermentation, plant farming, or autocrine cells succeed at scale">any approach works</abbr>) | <$1/kg | Likely negligible || **Partial success** | $5-20/kg | Significant but potentially manageable || **Limited progress** | $50-100+/kg | Could be prohibitive at scale |Why we frame this as "any one works": The breakthrough technologies (<abbr title="Using microbes to produce proteins at scale">precision fermentation</abbr>, <abbr title="Genetically modified plants producing growth factors">plant molecular farming</abbr>, <abbr title="Cells engineered to produce their own growth factors">autocrine cell lines</abbr>) are largely substitutes. If any one succeeds at scale, the problem is substantially addressed.This reasoning underlies our model's **<abbr title="Binary switch = the model treats each breakthrough technology as either 'adopted' or 'not adopted' (a Bernoulli draw with probability p). If adopted, growth factor costs drop to near-zero; if not, they remain high. This is a simplification — in reality, adoption is gradual and partial — but it captures the key economic bifurcation.">binary switch</abbr>** approach — though we acknowledge this is a simplification. Reality may involve partial successes or combinations of approaches.See [GFI's analysis](https://gfi.org/science/the-science-of-cultivated-meat/) for detailed technical roadmaps on each approach.Important caveat: a [2024 Nature Food scoping review](https://www.nature.com/articles/s43016-024-01061-3) of TEAs concluded: "TEAs published to date demonstrate that, under the current technological paradigm, CM is unlikely to be competitive with conventional meat." However, the review notes that "scale-up feasibility may hinge on cost-saving areas such as use of plant-based media components, food-grade aseptic conditions and extensive scaling of related supply chains.":::> *Most cheap-GF approaches (autocrine cell lines, precision fermentation, plant molecular farming) involve some form of genetic modification, so jurisdictions that restrict GM inputs may face structurally higher GF costs. Whether and how to fork CM_01 by regulatory environment is being discussed at the [workshop](https://uj-cm-workshop.netlify.app/).*---## Step 6: Harvest & Processing<span style="background: #e8f5e9; padding: 2px 8px; border-radius: 4px; font-size: 0.95em;">**Estimated cost share: <abbr title="Downstream processing is typically a small share at scale. Per Humbird 2021, centrifugation and processing add ~$0.10-0.50/kg. CE Delft (2021) estimates downstream at 2-15% of total, depending on product complexity — unstructured products (nuggets) are at the low end, structured products (steaks with scaffolding) could be higher.">2-15% of total production cost</abbr>** (lower for unstructured products like nuggets)</span>### Cell HarvestAfter cells reach target density, they're separated from the media using standard bioprocessing techniques ([Rathore et al. 2020](https://pubmed.ncbi.nlm.nih.gov/32115323/)):- **Centrifugation**: Spin to separate cells (~$0.10-0.50/kg)- **Filtration**: Tangential flow filtration through membranes- **Settling**: Allow cells to settle naturally (slowest but cheapest)### Forming Product (Downstream Processing)For **unstructured products** (ground meat, nuggets):- Mix cell paste with binders, fats, flavors- Form into shapes using standard food equipment- Minimal processing needed- **Cost: ~$2-5/kg** ([Risner et al. 2021](https://www.mdpi.com/2304-8158/10/1/3))For **structured products** (chicken breast, steak):- Requires scaffolds or 3D printing to organize fibers- Cells must align into muscle-like structures- Much more complex- **Cost: ~$5-20/kg additional** ([GFI 2021](https://gfi.org/science/the-science-of-cultivated-meat/))::: {.callout-note}Our model includes an optional "downstream processing" toggle that adds $2-15/kg for structured products.:::::: {.callout-warning collapse="true"}## Reality check: Scaffolding in 2026Industry sources suggest most companies have moved away from scaffolding for first-generation products:- Cannot achieve required cell densities with scaffolds- Most companies targeting unstructured products (mince, nuggets) first- Academic papers continue publishing scaffolding research, but this may not reflect current industry directionThe model's downstream processing toggle ($2-15/kg for structured products) should be treated as speculative for near-term projections. First commercial products are more likely to be unstructured or blended with plant-based ingredients.:::---## Cost Breakdown Summary*This diagram summarizes the <abbr title="Based on central estimates from multiple TEA models (Humbird 2021, Risner et al. 2021, CE Delft 2021, GFI 2024). Ranges reflect scenario variation across studies.">typical</abbr> cost structure and key levers for reduction, drawing on the components explained above: [media](#media-composition-the-food-for-cells), [growth factors](#step-5-growth-factors--a-key-cost-driver), [bioreactors](#step-3-production-bioreactors), and [cell density](#why-cell-density-is-so-important).*```{=html}<svg viewBox="0 0 800 380" style="width: 100%; max-width: 1000px; min-height: 480px; margin: 1.5rem auto; display: block;"> <rect width="800" height="380" fill="#f8f9fa" rx="8"/> <text x="400" y="30" text-anchor="middle" font-size="16" font-weight="bold" fill="#2c3e50">Typical Cost Breakdown ($/kg chicken)</text> <!-- Stacked bar --> <rect x="50" y="55" width="480" height="60" fill="#27ae60"/> <text x="290" y="92" text-anchor="middle" font-size="14" fill="white" font-weight="bold">Variable Costs (Media, GFs, etc.): 40-70%</text> <rect x="50" y="115" width="480" height="45" fill="#e74c3c"/> <text x="290" y="144" text-anchor="middle" font-size="13" fill="white" font-weight="bold">Capital Costs (Bioreactors): 15-35%</text> <rect x="50" y="160" width="480" height="38" fill="#f39c12"/> <text x="290" y="185" text-anchor="middle" font-size="13" fill="white" font-weight="bold">OPEX (Labor, Overhead, etc.): 10-25%</text> <!-- Breakdown detail --> <g transform="translate(560, 55)"> <rect x="0" y="0" width="220" height="145" fill="white" stroke="#ddd" rx="5"/> <text x="110" y="22" text-anchor="middle" font-size="12" font-weight="bold" fill="#2c3e50">Variable Cost Split</text> <rect x="10" y="34" width="200" height="18" fill="#27ae60"/> <text x="110" y="48" text-anchor="middle" font-size="10" fill="white">Media 30-50%</text> <rect x="10" y="54" width="200" height="18" fill="#9b59b6"/> <text x="110" y="68" text-anchor="middle" font-size="10" fill="white">Growth Factors*</text> <rect x="10" y="74" width="200" height="18" fill="#1abc9c"/> <text x="110" y="88" text-anchor="middle" font-size="10" fill="white">Micros 5-15%</text> <rect x="10" y="94" width="200" height="18" fill="#7f8c8d"/> <text x="110" y="108" text-anchor="middle" font-size="10" fill="white">Other 5-10%</text> <text x="110" y="128" text-anchor="middle" font-size="10" fill="#9b59b6">*0-60% depending</text> <text x="110" y="141" text-anchor="middle" font-size="10" fill="#9b59b6">on technology</text> </g> <!-- Key levers --> <text x="50" y="230" font-size="14" font-weight="bold" fill="#2c3e50">Key Cost Reduction Levers:</text> <circle cx="65" cy="258" r="9" fill="#27ae60"/> <text x="82" y="263" font-size="12" fill="#2c3e50">Hydrolysates: lowers 30-50% of media cost</text> <circle cx="65" cy="288" r="9" fill="#9b59b6"/> <text x="82" y="293" font-size="12" fill="#2c3e50">Cheap GFs: lowers 50-90% of GF cost (PIVOTAL)</text> <circle cx="65" cy="318" r="9" fill="#2c3e50"/> <text x="82" y="323" font-size="12" fill="#2c3e50">High cell density: lowers 50-80% of media volume</text> <circle cx="440" cy="258" r="9" fill="#e74c3c"/> <text x="457" y="263" font-size="12" fill="#2c3e50">Food-grade reactors: lowers 50-80% of CAPEX</text> <circle cx="440" cy="288" r="9" fill="#f39c12"/> <text x="457" y="293" font-size="12" fill="#2c3e50">Scale (larger plants): lowers 30-50% of fixed costs</text></svg>```*Note: Cell density reduces media volume needed per kg, affecting the green (media) cost component. It does not directly relate to micronutrients (teal).*Source: Cost breakdown ranges from [Humbird 2021](https://www.sciencedirect.com/science/article/pii/S2589014X21000026), [Risner et al. 2021](https://www.mdpi.com/2304-8158/10/1/3), [GFI 2021](https://gfi.org/science/the-science-of-cultivated-meat/), updated with data from [PMC 2024](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/), [Believer Meats 2024](https://www.nature.com/articles/s43016-024-01022-w), and a [2025 industry report](https://agfundernews.com/humbird-was-spectacularly-wrong-on-cultivated-meat-economics-says-report-as-vow-predicts-it-will-soon-be-unit-margin-positive).::: {.callout-note collapse="true"}## A Note on Sources (click to expand)Many foundational TEA analyses in this field date from 2021 (Humbird, Risner et al., CE Delft, GFI). These remain widely cited because they established the analytical frameworks still in use. Where possible, we supplement with more recent data:- **2024**: [Garrison et al. (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12241508/) — referenced throughout for cost projections (~$63/kg), cell density records (360 g/L), bioreactor CAPEX estimates, and media cost data; [Believer Meats Nature Food study](https://www.nature.com/articles/s43016-024-01022-w), [Nature Food scoping review](https://www.nature.com/articles/s43016-024-01061-3)- **2025**: [Industry cost survey](https://agfundernews.com/humbird-was-spectacularly-wrong-on-cultivated-meat-economics-says-report-as-vow-predicts-it-will-soon-be-unit-margin-positive) (Lever VC)The field is evolving rapidly. If you know of newer sources we should cite, please add a Hypothesis comment!:::> *Whether to specify CM_01 by jurisdiction (gene-editing-permissive vs restrictive markets, US vs EU vs Singapore) or stick with a global average is a workshop framing question — see the [workshop discussion](https://uj-cm-workshop.netlify.app/).*---## Further ResourcesThe full prioritized reading list lives on the [workshop resources page](https://uj-cm-workshop.netlify.app/resources). Three starting points:- [Goodwin, Aimutis & Shirwaiker (2024)](https://www.nature.com/articles/s43016-024-01100-z) — scoping review of TEAs (best single starting point)- [Humbird (2021)](https://www.sciencedirect.com/science/article/pii/S2589014X21000026) — pessimistic engineering baseline- [GFI amino acid report (2025)](https://gfi.org/resource/amino-acid-cost-and-supply-chain-analysis-for-cultivated-meat/) — supplier-quoted prices challenging Humbird's media assumptionsFor a side-by-side of how the major TEAs differ, see the [TEA comparison page](compare.qmd).---::: {.callout-tip}**Return to:** [Interactive Cost Model](index.qmd) | **Technical details:** [Documentation](docs.qmd) | **[Audio Review (MP3)](model_review_report.mp3)** | **[Workshop (May 2026)](https://uj-cm-workshop.netlify.app/)**:::